↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

1,916 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 (11c)pe2i - - - - 1件:  6  💬
2 (2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide) - - - - 1件:  6  💬
3 (3beta, 5beta, 25r)-spirostan-3-ol - - - - 1件:  6  💬
4 (3ß, 5ß, 25r)-spirostan-3-ol - - - - 1件:  6  💬
5 (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol - - - - 1件:  6  💬
6 (minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate - - - - 1件:  6  💬
7 (r)-troloxamide quinone - - - - 1件:  6  💬
8 (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol - - - - 1件:  6  💬
9 (s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate - - - - 1件:  6  💬
10 0 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
11 0.04 mg lu ae04621 - - - - 1件:  6  💬
12 0.08 mg lu ae04621 - - - - 1件:  6  💬
13 0.2 mg lu ae04621 - - - - 1件:  6  💬
14 0.3 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
15 0.4 mg lu ae04621 - - - - 1件:  6  💬
16 0.6 mg lu ae04621 - - - - 1件:  6  💬
17 0.8 mg lu ae04621 - - - - 1件:  6  💬
18 0.9% sodium chloride Chloride ion 1件: D02056 💬 - - 4件:  6 , 14, 51, 53 💬
19 0.9% sodium chloride (normal saline) Chloride ion 1件: D02056 💬 - - 1件:  6  💬
20 00000 - - - - 1件:  6  💬
21 000000 - - - - 1件:  6  💬
22 009-0 - - - - 1件:  6  💬
23 009-1 - - - - 1件:  6  💬
24 009-2 - - - - 1件:  6  💬
25 009-3 - - - - 1件:  6  💬
26 009-4 - - - - 1件:  6  💬
27 009-5 - - - - 1件:  6  💬
28 009-a0 - - - - 1件:  6  💬
29 009-a1 - - - - 1件:  6  💬
30 009-a2 - - - - 1件:  6  💬
31 009-a3 - - - - 1件:  6  💬
32 1 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
33 1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
34 1 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
35 1. tesofensine (ns 2330) Tesofensine - - - 1件:  6  💬
36 1.0 mg lu ae04621 - - - - 1件:  6  💬
37 1.0 mg rasagiline mesylate Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
38 1.2 mg lu ae04621 - - - - 1件:  6  💬
39 100 - - - - 2件:  6 , 97 💬
40 11c-methylreboxetine - - - - 2件:  6 , 17 💬
41 11c-pbr28 - - - - 2件:  6 , 13 💬
42 11c-pib - - - - 2件:  6 , 13 💬
43 11c-raclopride Raclopride - - - 1件:  6  💬
44 125 - - - - 1件:  6  💬
45 13n-ammonia Ammonia 1件: D02916 💬 - - 2件:  6 , 17 💬
46 15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
47 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
48 15o h2o - - - - 1件:  6  💬
49 18-fdtbz - - - - 1件:  6  💬
50 18f florbetaben - - - - 1件:  6  💬
51 18f- dtbz - - - - 1件:  6  💬
52 18f-av-133 Florbenazine F-18 - - - 1件:  6  💬
53 18f-av-45 - - - - 2件:  6 , 127 💬
54 18f-dopa - - - - 3件:  6 , 17, 75 💬
55 18f-dopa pet - - - - 1件:  6  💬
56 18f-dopamne - - - - 2件:  6 , 17 💬
57 18f-dtbz - - - - 1件:  6  💬
58 18f-dtbz av-133 - - - - 1件:  6  💬
59 18f-fdg Fludeoxyglucose (18F) - - - 12件:  5 ,  6 ,  7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬
60 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
61 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
62 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
63 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
64 2 mg perampanel Perampanel 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  6  💬
65 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide - - - - 1件:  6  💬
66 2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride - - - - 2件:  6 , 162 💬
67 200 mg bia 6-512 BIA - - - 1件:  6  💬
68 207-3120 - - - - 1件:  6  💬
69 240mg amantadine hcl er tablets Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
70 25 mg bia9 1067 - - - - 1件:  6  💬
71 25 mg ongentys - - - - 1件:  6  💬
72 25330 - - - - 1件:  6  💬
73 3 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
74 3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
75 3 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
76 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate - - - - 1件:  6  💬
77 3-(3,4-dihydroxyphenyl)-l-alanine Alanine 1件: D00012 💬 - - 1件:  6  💬
78 320mg amantadine hcl er tablets Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
79 4 mg perampanel Perampanel 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  6  💬
80 50 mg bia 9 1067 BIA - - - 1件:  6  💬
81 50 mg ongentys - - - - 1件:  6  💬
82 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
83 6aß - apomorphine-10,11-diol hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
84 7 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
85 7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
86 7-beta-hydroxyepiandrosterone 7-beta-Hydroxyepiandrosterone - - - 1件:  6  💬
87 75 - - - - 1件:  6  💬
88 8-ohdg 8-hydroxy-2'-deoxyguanosine - - - 1件:  6  💬
89 [11c]pbr28 - - - - 1件:  6  💬
90 [11c]pxt012253 - - - - 1件:  6  💬
91 [11c]smw139 - - - - 1件:  6  💬
92 [123i] 5-ia - - - - 1件:  6  💬
93 [123i] ibvm and spect imaging - - - - 1件:  6  💬
94 [123i] mzint injection and serial dynamic spect imaging - - - - 1件:  6  💬
95 [123i]-ibvm - - - - 1件:  6  💬
96 [123i]b-cit - - - - 1件:  6  💬
97 [123i]b-cit spect imaging - - - - 1件:  6  💬
98 [123i]beta cit - - - - 1件:  6  💬
99 [123i]beta cit and spect imaging - - - - 1件:  6  💬
100 [123i]beta-cit - - - - 1件:  6  💬
101 [123i]beta-cit and spect imaging - - - - 1件:  6  💬
102 [123i]clinde - - - - 2件:  6 , 13 💬
103 [123i]mni-420 - - - - 2件:  6 ,  8  💬
104 [123i]ß cit - - - - 1件:  6  💬
105 [123i]ß cit and spect imaging - - - - 1件:  6  💬
106 [123i]ß-cit - - - - 1件:  6  💬
107 [123i]ß-cit and spect imaging - - - - 1件:  6  💬
108 [14c]-bia 9-1067 BIA - - - 1件:  6  💬
109 [15o]h2o - - - - 1件:  6  💬
110 [18f] cfpypb - - - - 1件:  6  💬
111 [18f] lbt-999 - - - - 1件:  6  💬
112 [18f] lbt-999 pet - - - - 1件:  6  💬
113 [18f] pbr06 - - - - 2件:  6 , 13 💬
114 [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane - - - - 1件:  6  💬
115 [18f]-feppa - - - - 2件:  6 , 13 💬
116 [18f]dpa-714 pet scan - - - - 1件:  6  💬
117 [18f]fdopa - - - - 2件:  6 , 17 💬
118 [18f]fdopa pet/ct - - - - 1件:  6  💬
119 [18f]fe-pe2i - - - - 1件:  6  💬
120 [18f]fpeb - - - - 3件:  6 ,  8 , 206 💬
121 [18f]mk-9470 - - - - 1件:  6  💬
122 [18f]mni-1126 - - - - 1件:  6  💬
123 [18f]mppf - - - - 1件:  6  💬
124 [18f]nos - - - - 1件:  6  💬
125 [18f]p17-059 - - - - 1件:  6  💬
126 [18f]pi-2620 - - - - 2件:  6 , 127 💬
127 [18f]t807 ([18f]mni-777) - - - - 2件:  5 ,  6  💬
128 [21cfr640.30] plasma from 18 - 25 year old volunteer donors - - - - 1件:  6  💬
129 [abbv-951] - - - - 1件:  6  💬
130 [f-18] fluorodopa positron emission tomography - - - - 1件:  6  💬
131 [jnj31-31001074] - - - - 1件:  6  💬
132 [na] - - - - 7件:  6 , 11, 35, 46, 53, 65, 299 💬
133 A-dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
134 Aav2-gdnf - - - - 1件:  6  💬
135 Ab1010 - - - - 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
136 Abbv-0805 - - - - 1件:  6  💬
137 Abbv-951 - - - - 1件:  6  💬
138 Abt-slv187 - - - - 1件:  6  💬
139 Acamprosate Acamprosate 2件: D02780, D07058 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 2件:  6 , 206 💬
140 Accordion pill carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
141 Accordion pill ¿ carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
142 Accordion pill ¿ carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
143 Accordion pill? carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
144 Accordion pill? carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
145 Accordion pill™ carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
146 Accordion pill™ carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
147 Accordion pill™ carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
148 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
149 Acetylcysteine Acetylcysteine 1件: D00221 💬 - - 16件:  6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬
150 Acp-103 - - - - 1件:  6  💬
151 Acr325 ACR325 - - - 1件:  6  💬
152 Active comparator - - - - 2件:  6 , 46 💬
153 Active drug (biib014) at 10, 30, 100, or 300 mg once daily. - - - - 1件:  6  💬
154 Active drug: pimavanserin 17mg (2 strength tablets) Pimavanserin - - - 1件:  6  💬
155 Active investigational treatment ent-01 - - - - 1件:  6  💬
156 Ad-810n (zonisamide) Zonisamide 1件: D00538 💬 8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 1件:  6  💬
157 Adjuvant without active component - - - - 2件:  6 , 17 💬
158 Administration of stable isotope-labelled leucine- Leucine 1件: D00030 💬 - - 1件:  6  💬
159 Ads-5102 - - - - 2件:  6 , 13 💬
160 Ads-5102 (extended release amantadine hcl) Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
161 Adx48621 - - - - 1件:  6  💬
162 Affitope® pd01a - - - - 1件:  6  💬
163 Affitope® pd01a + adjuvant - - - - 2件:  6 , 17 💬
164 Afq056 - - - - 3件:  6 ,  8 , 206 💬
165 Afq056 with l-dopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
166 Afq065 - - - - 1件:  6  💬
167 Agomelatine Agomelatine 1件: D02578 💬 3件: HTR2C, MTNR1A, MTNR1B 💬 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
168 Agomelatine or piacebo Agomelatine 1件: D02578 💬 3件: HTR2C, MTNR1A, MTNR1B 💬 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
169 Aha - - - - 1件:  6  💬
170 Akst4290 - - - - 2件:  6 , 162 💬
171 Al - - - - 9件:  5 ,  6 ,  7 , 28, 51, 67, 86, 114, 127 💬
172 Alanine Alanine 1件: D00012 💬 - - 4件:  6 , 13, 298, 299 💬
173 Allogeneic bone marrow-derived mscs (1 x 10 6 msc/kg) - - - - 1件:  6  💬
174 Allogeneic bone marrow-derived mscs (10 x 10 6 msc/kg) - - - - 1件:  6  💬
175 Allogeneic bone marrow-derived mscs (3 x 10 6 msc/kg) - - - - 1件:  6  💬
176 Allogeneic bone marrow-derived mscs (6 x 10 6 msc/kg) - - - - 1件:  6  💬
177 Allopurinol Allopurinol 1件: D00224 💬 1件: XDH 💬 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 6件:  6 , 46, 57, 66, 96, 97 💬
178 Altropane Altropane - - - 1件:  6  💬
179 Altropane® Altropane - - - 1件:  6  💬
180 Amantadin-ratiopharm 100mg - - - - 1件:  6  💬
181 Amantadine Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 4件:  6 ,  8 , 13, 127 💬
182 Amantadine 300 mg Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
183 Amantadine hcl er Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
184 Amantadine hcl extended release Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
185 Amantadine hcl extended release capsule Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
186 Amantadine hydrochloride Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
187 Amantadine hydrochloride (hcl) Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
188 Amantadine sulfate Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
189 Ambrosan 60mg tablets - - - - 1件:  6  💬
190 Ambroxol Ambroxol 1件: D07442 💬 - - 2件:  6 , 19 💬
191 Ambroxol hydrochloride Ambroxol 1件: D07442 💬 - - 1件:  6  💬
192 Ammonia Ammonia 1件: D02916 💬 - - 4件:  6 , 17, 86, 88 💬
193 Amoxicillin Amoxicillin 3件: D00229, D02925, D07452 💬 - - 7件:  6 , 46, 63, 96, 97, 222, 299 💬
194 Ampreloxetine Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
195 Ampreloxetine chydrochloride Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
196 Ampreloxetine hydrochloride Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
197 Ampyra - - - - 2件:  6 , 13 💬
198 Ampyra first, - - - - 1件:  6  💬
199 Anavex2-73 - - - - 2件:  6 , 156 💬
200 Anhydrous carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
201 Anti-parkinson medication - - - - 5件:  5 ,  6 ,  7 ,  8 , 17 💬
202 Antiparkinsonian agent(s) - - - - 1件:  6  💬
203 Ap - - - - 4件:  2 ,  6 , 13, 299 💬
204 Ap-cd/ld - - - - 1件:  6  💬
205 Ap09004 - - - - 1件:  6  💬
206 Apl-130277 - - - - 1件:  6  💬
207 Aplindore Aplindore - - - 1件:  6  💬
208 Aplindore mr tablets Aplindore - - - 1件:  6  💬
209 Apo-go - - - - 1件:  6  💬
210 Apo-go® - - - - 1件:  6  💬
211 Apokinon - - - - 1件:  6  💬
212 Apokyn - - - - 1件:  6  💬
213 Apomor - - - - 1件:  6  💬
214 Apomorp - - - - 1件:  6  💬
215 Apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
216 Apomorphine 0.25% (2.5mg/ml) Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
217 Apomorphine hcl injection Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
218 Apomorphine hydrochloride Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
219 Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
220 Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
221 Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
222 Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
223 Apomorphine hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
224 Apomorphine hydrocloride Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
225 Apomorphine hydrocloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
226 Apomorphine infusion Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
227 Apomorphine nasal powder Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
228 Aporon - - - - 1件:  6  💬
229 Aqw051 - - - - 1件:  6  💬
230 Aricept - - - - 4件:  6 , 13, 78, 124 💬
231 Aricept 5 mg-filmtabletten - - - - 1件:  6  💬
232 Aricept 5mg-filmtabletten - - - - 1件:  6  💬
233 Aripiprazole Aripiprazole 1件: D01164 💬 4件: DRD2, DRD3, HTR1A, HTR2A 💬 12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 206 💬
234 Armodafinil Armodafinil 1件: D03215 💬 1件: SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 3件:  6 , 13, 84 💬
235 Artane - - - - 1件:  6  💬
236 As2 - - - - 1件:  6  💬
237 Asyn mab - - - - 1件:  6  💬
238 At 10 - - - - 1件:  6  💬
239 Atm fog in pd - - - - 1件:  6  💬
240 Atomoxetine Atomoxetine 2件: D02574, D07473 💬 1件: SLC6A2 💬 1件: Synaptic vesicle cycle 3件:  6 ,  8 , 13 💬
241 Atypical antipsychotics - - - - 1件:  6  💬
242 Autologous mesenchymal stem cells - - - - 5件:  2 ,  6 , 13, 17, 46 💬
243 Av-101 AV-101 - - - 1件:  6  💬
244 Avalox - - - - 1件:  6  💬
245 Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al - - - - 1件:  6  💬
246 Ave8112 - - - - 1件:  6  💬
247 Avp-923 - - - - 3件:  2 ,  6 , 13 💬
248 Avp-923-45 - - - - 1件:  6  💬
249 Azathioprine Azathioprine 2件: D00238, D03033 💬 - - 20件:  6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
250 Azd3241 - - - - 2件:  6 , 17 💬
251 Azd3241 300 mg bid - - - - 1件:  6  💬
252 Azd3241 600 mg bid - - - - 1件:  6  💬
253 Azd3241 alternative titration scheme with formulation 1 or 2 - - - - 1件:  6  💬
254 Azd3241 er formulation 1 - - - - 1件:  6  💬
255 Azd3241 extended release tablets 100 mg - - - - 1件:  6  💬
256 Azd3241 extended release tablets 25 mg - - - - 1件:  6  💬
257 Azilect - - - - 4件:  2 ,  5 ,  6 , 17 💬
258 Azilect 1 mg comprimidos - - - - 2件:  6 , 17 💬
259 Azilect 1mg - - - - 1件:  6  💬
260 Azilect® - - - - 1件:  6  💬
261 B-cit and spect imaging - - - - 1件:  6  💬
262 B6, b12, l-methylfolate Levomefolic acid 1件: D09353 💬 - - 1件:  6  💬
263 Balance Isoxaflutole - - - 9件:  5 ,  6 , 13, 46, 81, 113, 122, 149, 299 💬
264 Band - - - - 2件:  6 , 97 💬
265 Bavisant Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
266 Bavisant dihydrochloride monohydrate Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
267 Bavisant hydrochloride monohydrate Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
268 Beam Tricyclazole - - - 2件:  6 , 51 💬
269 Bee venom - - - - 1件:  6  💬
270 Behavioral: assessment of cognition - - - - 1件:  6  💬
271 Behavioral: assessment of depression - - - - 1件:  6  💬
272 Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors - - - - 1件:  6  💬
273 Behavioral: assessment of quality of life - - - - 1件:  6  💬
274 Behavioral: assessment of severity of icd (impulse control disorders) - - - - 1件:  6  💬
275 Behavioral: assessment of severity of parkinson disease - - - - 1件:  6  💬
276 Behavioral: attention control - - - - 1件:  6  💬
277 Behavioral: augmented reality multi-modal training - - - - 1件:  6  💬
278 Behavioral: balance & strengthening exercises Isoxaflutole - - - 1件:  6  💬
279 Behavioral: balance training Isoxaflutole - - - 2件:  6 , 13 💬
280 Behavioral: bci-fit active querying - - - - 3件:  2 ,  6 , 17 💬
281 Behavioral: bci-fit adaptive signal modeling - - - - 3件:  2 ,  6 , 17 💬
282 Behavioral: bci-fit language modeling - - - - 3件:  2 ,  6 , 17 💬
283 Behavioral: bci-fit multi-modal access - - - - 3件:  2 ,  6 , 17 💬
284 Behavioral: brisk walking and balance training Isoxaflutole - - - 1件:  6  💬
285 Behavioral: building better caregivers workshop - - - - 1件:  6  💬
286 Behavioral: cbt and sleep hygiene - - - - 1件:  6  💬
287 Behavioral: co-op treatment protocol - - - - 1件:  6  💬
288 Behavioral: cognitive and behavioral experimental tasks - - - - 2件:  6 , 127 💬
289 Behavioral: combined balance and brisk walking training Isoxaflutole - - - 1件:  6  💬
290 Behavioral: conservative measures for orthostatic hypotension - - - - 2件:  6 , 17 💬
291 Behavioral: dexterity - - - - 1件:  6  💬
292 Behavioral: dual task - - - - 1件:  6  💬
293 Behavioral: ecocapture - - - - 2件:  6 , 127 💬
294 Behavioral: emotion assessment - - - - 1件:  6  💬
295 Behavioral: exercise - - - - 3件:  6 , 265, 299 💬
296 Behavioral: exercise only - - - - 1件:  6  💬
297 Behavioral: exercise+multi-modal sensory feedback (mmsf) - - - - 1件:  6  💬
298 Behavioral: flexibility and strengthening exercise - - - - 1件:  6  💬
299 Behavioral: gait and balance Isoxaflutole - - - 1件:  6  💬
300 Behavioral: gait and balance training program Isoxaflutole - - - 1件:  6  💬
301 Behavioral: healthy age-matched controls - - - - 1件:  6  💬
302 Behavioral: icm_apathy_tasks - - - - 2件:  6 , 127 💬
303 Behavioral: levodopa or acupuncture Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
304 Behavioral: low-impact exercise control - - - - 1件:  6  💬
305 Behavioral: memory - - - - 1件:  6  💬
306 Behavioral: participant open-response writing - - - - 1件:  6  💬
307 Behavioral: participant self-assessment surveys - - - - 1件:  6  💬
308 Behavioral: pat sessions - - - - 1件:  6  💬
309 Behavioral: pelvic floor muscle exercise-based behavioral therapy - - - - 1件:  6  💬
310 Behavioral: phonation - - - - 1件:  6  💬
311 Behavioral: physical exam and updrs part iii assessment - - - - 1件:  6  💬
312 Behavioral: physical therapy - - - - 1件:  6  💬
313 Behavioral: resistance training - - - - 1件:  6  💬
314 Behavioral: rest - - - - 1件:  6  💬
315 Behavioral: role of dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
316 Behavioral: single task - - - - 1件:  6  💬
317 Behavioral: strength training - - - - 1件:  6  💬
318 Behavioral: stretching - - - - 1件:  6  💬
319 Behavioral: tai chi - - - - 1件:  6  💬
320 Behavioral: traditional multi-modal training - - - - 1件:  6  💬
321 Behavioral: upper limb exercise - - - - 1件:  6  💬
322 Ben-2001 - - - - 1件:  6  💬
323 Benserazide Benserazide 1件: D03082 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
324 Benserazide hydrochloride Benserazide 1件: D03082 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
325 Benzofuran Benzofuran - - - 1件:  6  💬
326 Berachin - - - - 1件:  6  💬
327 Best medical treatment - - - - 1件:  6  💬
328 Best médical treatment - - - - 1件:  6  💬
329 Betaquik mct supplement - - - - 1件:  6  💬
330 Better - - - - 1件:  6  💬
331 Bf 2.649 - - - - 1件:  6  💬
332 Bf 2.649 10 mg - - - - 1件:  6  💬
333 Bf 2.649 20 mg - - - - 1件:  6  💬
334 Bf 2.649 40 mg - - - - 1件:  6  💬
335 Bf 2.649 5 mg - - - - 1件:  6  💬
336 Bf2.649 - - - - 1件:  6  💬
337 Bf2.649 (pitolisant) Pitolisant 1件: D10749 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
338 Bi-sifrol® - - - - 1件:  6  💬
339 Bia BIA - - - 2件:  6 , 86 💬
340 Bia 3-202 BIA - - - 1件:  6  💬
341 Bia 3-202 (200 mg) BIA - - - 1件:  6  💬
342 Bia 6-512 BIA - - - 1件:  6  💬
343 Bia 6-512 100 mg BIA - - - 1件:  6  💬
344 Bia 6-512 100 mg dose BIA - - - 1件:  6  💬
345 Bia 6-512 200 mg dose BIA - - - 1件:  6  💬
346 Bia 6-512 25 mg BIA - - - 1件:  6  💬
347 Bia 6-512 25 mg dose BIA - - - 1件:  6  💬
348 Bia 6-512 400 mg BIA - - - 1件:  6  💬
349 Bia 6-512 50 mg dose BIA - - - 1件:  6  💬
350 Bia 9-1067 BIA - - - 1件:  6  💬
351 Bia 9-1067 (test) BIA - - - 1件:  6  💬
352 Bia 9-1067 15 mg BIA - - - 1件:  6  💬
353 Bia 9-1067 25 mg BIA - - - 1件:  6  💬
354 Bia 9-1067 30 mg BIA - - - 1件:  6  💬
355 Bia 9-1067 5 mg BIA - - - 1件:  6  💬
356 Bia 9-1067 micronized BIA - - - 1件:  6  💬
357 Bia 9-1067 non-micronized BIA - - - 1件:  6  💬
358 Biib014 - - - - 1件:  6  💬
359 Biib054 - - - - 1件:  6  💬
360 Biib094 - - - - 1件:  6  💬
361 Bisphosphonates - - - - 2件:  6 , 274 💬
362 Bone marrow derived mesenchymal stem cells - - - - 2件:  6 , 60 💬
363 Bont-a - - - - 1件:  6  💬
364 Botox - - - - 6件:  2 ,  6 , 13, 51, 149, 226 💬
365 Botulinum toxin - - - - 3件:  6 , 13, 149 💬
366 Botulinum toxin type a Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 10件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 70, 113, 149 💬
367 Botulinum toxin type b Botulinum Toxin Type B 1件: D02735 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 3件:  2 ,  6 , 51 💬
368 Botulinum toxin type b (myobloc) Botulinum Toxin Type B 1件: D02735 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 2件:  2 ,  6  💬
369 Botulinum toxin: xeomin - - - - 1件:  6  💬
370 Bromocriptine Bromocriptine 2件: D00780, D03165 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 74 💬
371 Bromocriptine and other dopamine agonists Bromocriptine 4件: D00633, D00780, D03165, D07870 💬 6件: DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
372 Btrx-246040 BTRX-246040 - - - 1件:  6  💬
373 Btx-a Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件:  6  💬
374 Bumetanide Bumetanide 1件: D00247 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 2件:  6 , 158 💬
375 Bumetanide white, oblong, scored tablet Bumetanide 1件: D00247 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 1件:  6  💬
376 Bupleurum+ginkgo Ginkgo biloba - - - 1件:  6  💬
377 Buspirone Buspirone 2件: D00702, D07593 💬 2件: DRD2, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 51 💬
378 Buspirone hydrochloride Buspirone 2件: D00702, D07593 💬 2件: DRD2, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
379 Butylphthalide Butylphthalide - - - 4件:  2 ,  6 , 18, 22 💬
380 Bydureon - - - - 2件:  6 , 17 💬
381 Bydureon 2 mg powder and solvent for prolonged-release suspension - - - - 1件:  6  💬
382 Byetta - - - - 2件:  6 , 193 💬
383 Byetta 5 micrograms - - - - 1件:  6  💬
384 Cabaser - - - - 1件:  6  💬
385 Cabaseril - - - - 1件:  6  💬
386 Cabaseril, 1,0 mg tablette - - - - 1件:  6  💬
387 Cabaseril, 2,0 mg tablette - - - - 1件:  6  💬
388 Cabergolina Cabergoline 1件: D00987 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
389 Cabergoline Cabergoline 1件: D00987 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 , 74, 75 💬
390 Caffeine Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 9件:  2 ,  6 , 13, 21, 46, 78, 96, 97, 265 💬
391 Caffeine 100-200 mg bid Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
392 Caffeine alkaloid Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
393 Calcium Calcium - - - 27件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
394 Cannabidiol Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 17件:  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
395 Cannabidiol (cbd) Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 6件:  6 , 140, 144, 145, 156, 158 💬
396 Cannabis Medical Cannabis - - - 8件:  2 ,  6 , 13, 46, 90, 96, 97, 271 💬
397 Cannabis oil Medical Cannabis - - - 1件:  6  💬
398 Cannabis, medical Medical Cannabis - - - 5件:  2 ,  6 , 13, 96, 97 💬
399 Capsaicin Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 5件:  2 ,  6 , 19, 86, 226 💬
400 Capsaicin vapor Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件:  6  💬
401 Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
402 Capture Bifenthrin - - - 2件:  6 , 46 💬
403 Carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
404 Carbidopa (fu) Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
405 Carbidopa 20 mg Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
406 Carbidopa 200mg oral dose Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
407 Carbidopa 27.5 mg Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
408 Carbidopa 65 mg capsule Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
409 Carbidopa and levodopa 25mg/100mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
410 Carbidopa and levodopa tablets, usp Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
411 Carbidopa anidra Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
412 Carbidopa fu Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
413 Carbidopa inn Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
414 Carbidopa levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
415 Carbidopa monohydrate Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
416 Carbidopa, levodopa, entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
417 Carbidopa- levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
418 Carbidopa-4'-monophosphate Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
419 Carbidopa-levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 3件:  2 ,  4 ,  6  💬
420 Carbidopa-levodopa 25 mg-100 mg oral tablet Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
421 Carbidopa/l-dopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
422 Carbidopa/l-dopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
423 Carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
424 Carbidopa/levodopa, immediate release Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
425 Carbidopa/levodopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
426 Carbidopamonohydraat - - - - 1件:  6  💬
427 Carbodopa levadopa - - - - 1件:  6  💬
428 Carbodopa/levadopa - - - - 1件:  6  💬
429 Carbon Activated charcoal 1件: D03251 💬 - - 9件:  6 , 46, 50, 51, 85, 86, 96, 97, 298 💬
430 Carnosine Carnosine - - - 2件:  6 , 13 💬
431 Carnosine supplementation Carnosine - - - 1件:  6  💬
432 Carvedilol Carvedilol 2件: D00255, D03415 💬 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 57, 86, 113, 210 💬
433 Catapres ampoules - - - - 1件:  6  💬
434 Catapressan - - - - 1件:  6  💬
435 Cbd - - - - 11件:  2 ,  6 ,  8 , 13, 46, 140, 144, 145, 156, 158, 206 💬
436 Cd - - - - 6件:  6 , 46, 51, 96, 97, 265 💬
437 Cd-ld cr - - - - 1件:  6  💬
438 Cd-ld ir - - - - 1件:  6  💬
439 Cdnf - - - - 1件:  6  💬
440 Ceftriaxone Ceftriaxone 2件: D00924, D07659 💬 - - 3件:  2 ,  6 , 97 💬
441 Cep-1347 CEP-1347 - - - 1件:  6  💬
442 Cep-1347 10mg CEP-1347 - - - 1件:  6  💬
443 Cep-1347 50mg CEP-1347 - - - 1件:  6  💬
444 Cep1347 - - - - 1件:  6  💬
445 Cep1347 25mg - - - - 1件:  6  💬
446 Cere-120 - - - - 1件:  6  💬
447 Cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn]) - - - - 1件:  6  💬
448 Cere-120: adeno-associated virus delivery of neurturin - - - - 1件:  6  💬
449 Cerebral dopamine neurotrophic factor Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
450 Ceretec - - - - 1件:  6  💬
451 Ceretec (tm) estabilizado - - - - 1件:  6  💬
452 Champix - - - - 1件:  6  💬
453 Chloride Chloride ion - - - 25件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬
454 Chocolate Cocoa - - - 1件:  6  💬
455 Cipralex - - - - 1件:  6  💬
456 Circadin - - - - 3件:  6 , 13, 90 💬
457 Circadin® - - - - 1件:  6  💬
458 Citalopram Citalopram 2件: D00822, D07704 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 6件:  6 ,  8 , 13, 18, 46, 127 💬
459 Citalopram 20mg Citalopram 2件: D00822, D07704 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
460 Cjh1 (clr4001) - - - - 1件:  6  💬
461 Clarithromycin Clarithromycin 1件: D00276 💬 - - 8件:  6 , 63, 84, 96, 97, 222, 228, 299 💬
462 Clarithromycin (not used as of 4/2020) Clarithromycin 1件: D00276 💬 - - 1件:  6  💬
463 Clarium 50 mg retardtabletten - - - - 1件:  6  💬
464 Clartihromycin, amoxicillin, and omeprazole Amoxicillin 7件: D00229, D00455, D01207, D02925, D05259, D05261, D07452 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件:  6  💬
465 Cle - - - - 1件:  6  💬
466 Clenbuterol Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 4件:  1 ,  2 ,  6 , 256 💬
467 Clenbuterol hcl Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
468 Clenbuterol hydrochloride Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
469 Clonazepam Clonazepam 1件: D00280 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
470 Clonidine Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 2件:  6 , 78 💬
471 Clonidine hydrochloride Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 2件:  6 , 78 💬
472 Clozapine Clozapine 1件: D00283 💬 11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 1件:  6  💬
473 Co - - - - 5件:  6 , 13, 53, 70, 85 💬
474 Cocoa Cocoa - - - 1件:  6  💬
475 Coenzyme q10 Ubidecarenone 1件: D01065 💬 - - 12件:  2 ,  5 ,  6 ,  8 , 10, 18, 46, 57, 113, 193, 214, 215 💬
476 Coenzyme q10 nanodispersion (nanoquinone) Ubidecarenone 1件: D01065 💬 - - 1件:  6  💬
477 Coenzyme q10 with vitamin e Ubidecarenone 2件: D01065, D02331 💬 - - 1件:  6  💬
478 Cofactor - - - - 3件:  6 , 265, 288 💬
479 Cogane - - - - 1件:  6  💬
480 Cogane™ (pym50028) - - - - 1件:  6  💬
481 Cohort 1:nilotinib oral capsules (150mg or 300mg) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
482 Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
483 Combination injection of epo and g-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
484 Combination product: l-dopa 140 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
485 Combination product: l-dopa 35 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
486 Combination product: l-dopa 70mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
487 Combination product: l-dopa 70mg/carbidopa 7mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
488 Combination product: nd0612 solution for sc infusion - - - - 1件:  6  💬
489 Comparator: carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
490 Comparator: levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
491 Comtan - - - - 1件:  6  💬
492 Comtan 200* 60 cpr 200 mg - - - - 1件:  6  💬
493 Comtan® - - - - 1件:  6  💬
494 Comtanâ® - - - - 1件:  6  💬
495 Comtess - - - - 1件:  6  💬
496 Comtess® - - - - 1件:  6  💬
497 Continuous apomorphine infusion Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
498 Continuous intrajejunal infusion of levodopa-carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
499 Continuous release dopamine agonists Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
500 Continuous subcutaneous lisuride infusion Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
501 Control - - - - 4件:  6 , 46, 168, 299 💬
502 Controlled-release levodopa / carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
503 Coq10 - - - - 3件:  5 ,  6 ,  8  💬
504 Cord blood therapy Umbilical Cord Blood Hematopoietic Stem Cells - - - 2件:  2 ,  6  💬
505 Cortef - - - - 3件:  6 , 81, 83 💬
506 Cp - - - - 6件:  6 , 46, 96, 97, 107, 271 💬
507 Creatine Creatine - - - 12件:  1 ,  2 ,  5 ,  6 ,  8 , 13, 46, 49, 50, 113, 156, 201 💬
508 Cst-103 - - - - 1件:  6  💬
509 Cst-139 - - - - 1件:  6  💬
510 Cu(ii)atsm - - - - 2件:  2 ,  6  💬
511 Cvd00118-e - - - - 1件:  6  💬
512 Cvl-751 - - - - 1件:  6  💬
513 Cvn424 high dose - - - - 1件:  6  💬
514 Cvn424 low dose - - - - 1件:  6  💬
515 Cvt-301 - - - - 1件:  6  💬
516 Cvt-301 (dose level 1) - - - - 1件:  6  💬
517 Cvt-301 (dose level 2) - - - - 1件:  6  💬
518 Cvt-301 35mg - - - - 1件:  6  💬
519 Cvt-301 50mg - - - - 1件:  6  💬
520 Cvt-301 high dose - - - - 1件:  6  💬
521 Cvt-301 low dose - - - - 1件:  6  💬
522 Cvt-301, lip - - - - 1件:  6  💬
523 Cvxl-0107 - - - - 1件:  6  💬
524 Cx-8998 - - - - 1件:  6  💬
525 Cyberknife - - - - 1件:  6  💬
526 Cymbalta - - - - 3件:  6 , 13, 49 💬
527 Cysteine Cysteine 2件: D00026, D02326 💬 - - 11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
528 Cystoscopic injection of botox into the urinary bladder - - - - 1件:  6  💬
529 D-serine D-Serine 1件: D00016 💬 - - 1件:  6  💬
530 D-serine (~2g/day) D-Serine 1件: D00016 💬 - - 1件:  6  💬
531 Da-9701 - - - - 1件:  6  💬
532 Da-9805 45mg - - - - 1件:  6  💬
533 Da-9805 90mg - - - - 1件:  6  💬
534 Daaoi-p - - - - 1件:  6  💬
535 Dacepton 5 mg/ml - - - - 1件:  6  💬
536 Dacepton 5 mg/ml infuusioneste, liuos - - - - 1件:  6  💬
537 Daily ingestion of lactobacillus plantarum ps128 Lactobacillus plantarum - - - 1件:  6  💬
538 Darifenacin Darifenacin 2件: D01699, D03654 💬 1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 2件:  6 , 13 💬
539 Dark chocolate (85% cocoa) Cocoa - - - 1件:  6  💬
540 Datscan - - - - 4件:  2 ,  5 ,  6 , 17 💬
541 Datscan 74 mbq/ml solution for injection - - - - 1件:  6  💬
542 Datscan™ - - - - 1件:  6  💬
543 Datscan™ ioflupane (123i) injection - - - - 3件:  5 ,  6 , 17 💬
544 Dc158am - - - - 1件:  6  💬
545 Dci - - - - 2件:  6 , 299 💬
546 Dcs - - - - 1件:  6  💬
547 Deanol Deanol 1件: D07777 💬 - - 1件:  6  💬
548 Deanol pyroglutamate Deanol 1件: D07777 💬 - - 1件:  6  💬
549 Debrumyl - - - - 1件:  6  💬
550 Deferiprone Deferiprone 1件: D07416 💬 - - 6件:  2 ,  6 , 18, 120, 122, 233 💬
551 Deferiprone (ferriprox) Deferiprone 1件: D07416 💬 - - 1件:  6  💬
552 Deferiprone 20mg Deferiprone 1件: D07416 💬 - - 1件:  6  💬
553 Deferiprone 30mg Deferiprone 1件: D07416 💬 - - 1件:  6  💬
554 Deferiprone 600 mg delayed release tablet Deferiprone 1件: D07416 💬 - - 1件:  6  💬
555 Deferiprone dr Deferiprone 1件: D07416 💬 - - 1件:  6  💬
556 Desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件:  6 , 17, 120, 156 💬
557 Desipramine (dmi) Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
558 Desmopressin Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 5件:  6 , 64, 72, 225, 288 💬
559 Desmopressin acetat Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件:  6  💬
560 Desmotabs - - - - 1件:  6  💬
561 Desmotabs® 0,2 mg tabletten - - - - 1件:  6  💬
562 Desmotabs® 0,2mg tabletten - - - - 1件:  6  💬
563 Determination of drug effects through amantadine cessation Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
564 Device: abdominal compression - - - - 2件:  6 , 17 💬
565 Device: actimyo recording - - - - 1件:  6  💬
566 Device: active tdcs - - - - 1件:  6  💬
567 Device: active tpcs - - - - 1件:  6  💬
568 Device: adaptor: hakko adaptor - - - - 1件:  6  💬
569 Device: aha exergame system - - - - 1件:  6  💬
570 Device: b-stn dbs - - - - 1件:  6  💬
571 Device: balance training Isoxaflutole - - - 1件:  6  💬
572 Device: balance training with nintendo wii fit Isoxaflutole - - - 1件:  6  💬
573 Device: cadd-legacy ambulatory infusion pump - - - - 1件:  6  💬
574 Device: cadd-legacy® 1400 ambulatory infusion pump - - - - 1件:  6  💬
575 Device: carbon fiber ankle foot orthosis (afo) Activated charcoal 1件: D03251 💬 - - 1件:  6  💬
576 Device: clonidine (catapressan) Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
577 Device: deep brain stimulation - - - - 5件:  5 ,  6 ,  7 ,  8 , 17 💬
578 Device: functional magnetic resonance imaging - - - - 1件:  6  💬
579 Device: infusion pump: cadd-legacy® 1400 pump - - - - 1件:  6  💬
580 Device: inspiratory muscle training - - - - 1件:  6  💬
581 Device: j-tube - - - - 1件:  6  💬
582 Device: jejunal extension tube - - - - 1件:  6  💬
583 Device: jejunal extension tube (j-tube) - - - - 1件:  6  💬
584 Device: kinetra and soletra (neurostimulator, medtronic) - - - - 1件:  6  💬
585 Device: light box ( litebook company) - - - - 1件:  6  💬
586 Device: light box (litebook company) - - - - 1件:  6  💬
587 Device: magnetic resonance imaging - - - - 5件:  6 , 13, 22, 34, 299 💬
588 Device: massage with a spiky ball - - - - 1件:  6  💬
589 Device: ms band 2 - - - - 1件:  6  💬
590 Device: nebulizer - - - - 1件:  6  💬
591 Device: nj-tube: silicon ed tube Silicon - - - 1件:  6  💬
592 Device: oct - tce - - - - 1件:  6  💬
593 Device: peg tube - - - - 1件:  6  💬
594 Device: percutaneous endoscopic gastrostomy tube - - - - 1件:  6  💬
595 Device: percutaneous endoscopic gastrostomy tube (peg tube) - - - - 1件:  6  💬
596 Device: renishaw drug delivery system - - - - 1件:  6  💬
597 Device: resistive respiratory loads - - - - 1件:  6  💬
598 Device: sham compression - - - - 2件:  6 , 17 💬
599 Device: sham tdcs - - - - 1件:  6  💬
600 Device: sham tpcs - - - - 1件:  6  💬
601 Device: spect imaging - - - - 1件:  6  💬
602 Device: spoton balance glasses Isoxaflutole - - - 1件:  6  💬
603 Device: stimulator off - - - - 1件:  6  💬
604 Device: stimulator on - - - - 1件:  6  💬
605 Dexdor - - - - 4件:  2 ,  4 ,  6 , 70 💬
606 Dexmedetomidina Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
607 Dexmedetomidine Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
608 Dexmedetomidine hydrochloride infusion Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
609 Dextromethorphan Dextromethorphan 3件: D00848, D03742, D03744 💬 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 11件:  2 ,  6 ,  8 , 13, 21, 46, 78, 85, 96, 97, 156 💬
610 Dha - - - - 8件:  6 , 46, 48, 49, 94, 113, 299, 301 💬
611 Diagnostic test: [18f]-ro6958948 - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
612 Diagnostic test: auto-assessment manikins (sam) - - - - 1件:  6  💬
613 Diagnostic test: barcelona test (bt) - - - - 1件:  6  💬
614 Diagnostic test: beam test to predict falls Tricyclazole - - - 1件:  6  💬
615 Diagnostic test: beck depression inventory-ii (bdi-ii) - - - - 1件:  6  💬
616 Diagnostic test: elecsys (roche) abeta42, ttau and ptau - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
617 Diagnostic test: flutemetamol f18 injection Flutemetamol 1件: D10231 💬 - - 5件:  5 ,  6 ,  7 , 17, 127 💬
618 Diagnostic test: frontal assessment battery (fab) - - - - 1件:  6  💬
619 Diagnostic test: global deterioration scale (gds) - - - - 1件:  6  💬
620 Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
621 Diagnostic test: measurement of serum level of anti-dementia drug - - - - 1件:  6  💬
622 Diagnostic test: memory alteration test (m@t) - - - - 1件:  6  💬
623 Diagnostic test: mini cognitive examination (mce) - - - - 1件:  6  💬
624 Diagnostic test: neuropsychological assessment - - - - 2件:  6 , 127 💬
625 Diagnostic test: positive and negative affect scale (panas) - - - - 1件:  6  💬
626 Diagnostic test: respiratory muscle strength - - - - 1件:  6  💬
627 Diagnostic test: rey-osterrieth complex figure test (rocft) - - - - 1件:  6  💬
628 Diagnostic test: spanish-complutense verbal learning test (tavec) - - - - 1件:  6  💬
629 Diagnostic test: supplementary neuropsychological assessment - parkinson's disease - - - - 2件:  6 , 127 💬
630 Different diets - - - - 1件:  6  💬
631 Dihydroergotoxine mesylate Ergoloid mesylate 1件: D02268 💬 6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
632 Dipivefrin Dipivefrin 1件: D02349 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
633 Dipivefrine Dipivefrin 1件: D02349 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
634 Dipraglurant Dipraglurant - - - 1件:  6  💬
635 Ditropan elixir - - - - 1件:  6  💬
636 Dm - - - - 2件:  6 ,  8  💬
637 Dm-1992 - - - - 1件:  6  💬
638 Dmi - - - - 2件:  6 , 17 💬
639 Dnl151 - - - - 1件:  6  💬
640 Dnl201 - - - - 1件:  6  💬
641 Dns-7801 (high dose) - - - - 1件:  6  💬
642 Dns-7801 (low-dose) - - - - 1件:  6  💬
643 Docosahexaenoic acid Doconexent - - - 7件:  6 , 49, 90, 94, 240, 299, 301 💬
644 Docosahexaenoic acid (dha) Doconexent - - - 3件:  6 , 94, 299 💬
645 Domperidone Domperidone 2件: D01745, D07868 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 5件:  6 , 13, 17, 51, 230 💬
646 Domperidone (drug) Domperidone 2件: D01745, D07868 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
647 Dompéridone - - - - 1件:  6  💬
648 Donepezil Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
649 Donepezil hydrochloride Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  6 , 124, 156 💬
650 Donepezil sandoz Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
651 Dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 ,  7 , 74 💬
652 Dopamine agent Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
653 Dopamine agonists (pramipexole, ropirinole) Dopamine 4件: D00559, D00633, D05575, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
654 Dopaminergic agonist + apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
655 Dopaminergic agonists - - - - 1件:  6  💬
656 Dops Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件:  6 , 17 💬
657 Doxepin Doxepin 2件: D00814, D07875 💬 3件: HRH1, SLC6A2, SLC6A4 💬 5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
658 Doxepin and zopiclone Doxepin 3件: D00814, D01372, D07875 💬 19件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 1件:  6  💬
659 Dpa - - - - 4件:  2 ,  6 , 13, 85 💬
660 Dpa-714-pet/mri - - - - 1件:  6  💬
661 Droxidopa Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件:  5 ,  6 , 17 💬
662 Droxidopa 100 mg [northera] Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
663 Duloxetine Duloxetine 2件: D01179, D07880 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 13 💬
664 Duloxetine hydrochloride Duloxetine 2件: D01179, D07880 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
665 Duodopa - - - - 1件:  6  💬
666 Duodopa gel intestinale - - - - 1件:  6  💬
667 Duodopa intestinal gel - - - - 1件:  6  💬
668 Duodopa intestinalgel - - - - 1件:  6  💬
669 Duodopa ld/cd 20/5 mg/ml - - - - 1件:  6  💬
670 Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel - - - - 1件:  6  💬
671 Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
672 Duodopa®intestinal gel - - - - 1件:  6  💬
673 Dynacirc cr (isradipine) Isradipine 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
674 E2007 - - - - 2件:  6 , 144 💬
675 Ebixa - - - - 3件:  2 ,  6 , 13 💬
676 Ebixa® - - - - 1件:  6  💬
677 Egcg Epigallocatechin gallate - - - 9件:  6 ,  8 , 13, 17, 28, 85, 113, 206, 299 💬
678 Elc200 - - - - 1件:  6  💬
679 Eliprodil Eliprodil - - - 1件:  6  💬
680 Elobixibat Elobixibat 1件: D10796 💬 1件: SLC10A2 💬 1件: Bile secretion 1件:  6  💬
681 Eltoprazine Eltoprazine - - - 1件:  6  💬
682 Eltoprazine hcl Eltoprazine - - - 1件:  6  💬
683 Eltoprazine hydrochloride Eltoprazine - - - 1件:  6  💬
684 Emd 128130 - - - - 2件:  6 , 156 💬
685 Emd128130 - - - - 1件:  6  💬
686 En - - - - 3件:  6 , 46, 97 💬
687 Ena713 - - - - 2件:  6 , 13 💬
688 Ena713b - - - - 1件:  6  💬
689 Ent-01 - - - - 1件:  6  💬
690 Entacapon - - - - 1件:  6  💬
691 Entacapona Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
692 Entacapone Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
693 Entacapone 400mg oral dose Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
694 Entacapone and carbidopa Carbidopa 2件: D00558, D00781 💬 2件: COMT, DDC 💬 10件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
695 Entacapone inn Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
696 Entecapone - - - - 1件:  6  💬
697 Epi-589 EPI-589 - - - 2件:  2 ,  6  💬
698 Epi-743 200mg - - - - 1件:  6  💬
699 Epi-743 400mg - - - - 1件:  6  💬
700 Equal - - - - 5件:  6 , 13, 67, 86, 230 💬
701 Er cd-ld - - - - 1件:  6  💬
702 Er tablet 100 mg azd3241 - - - - 1件:  6  💬
703 Er tablet 25 mg azd3241 - - - - 1件:  6  💬
704 Eradication of helcobacter pylori - - - - 1件:  6  💬
705 Eradication therapy for h.pylori infection - - - - 1件:  6  💬
706 Eradication therapy for helicobacter pylori - - - - 1件:  6  💬
707 Erythromycin Erythromycin 9件: D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 💬 - - 5件:  6 , 36, 164, 228, 291 💬
708 Erythropoietin Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 9件:  2 ,  6 , 13, 18, 22, 47, 70, 95, 96 💬
709 Erythropoietin human recombinant (eporh) Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
710 Escitalopram Escitalopram 3件: D02567, D07704, D07913 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 3件:  2 ,  6 , 13 💬
711 Escitalopram oxalate Escitalopram 3件: D02567, D07704, D07913 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
712 Eszopiclone Eszopiclone 1件: D02624 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 3件:  6 , 13, 46 💬
713 Ethnodyne visio - - - - 1件:  6  💬
714 Ethylmethylcarbamic acid 3-[(1s)-1-(dimethylamino)ethyl]phenyl ester (**see other 2 names below) - - - - 1件:  6  💬
715 Exametazime Exametazime 1件: D01109 💬 - - 1件:  6  💬
716 Exelon - - - - 2件:  6 , 13 💬
717 Exelon 4.6 mg/24 h transdermal patch - - - - 1件:  6  💬
718 Exelon 9.5 mg/24 h transdermal patch - - - - 1件:  6  💬
719 Exelon patch - - - - 1件:  6  💬
720 Exelon patch (rivastigmine transdermal system) Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
721 Exelon path transdermal - - - - 1件:  6  💬
722 Exelon ® - - - - 1件:  6  💬
723 Exenatide Exenatide 1件: D04121 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 4件:  6 , 17, 193, 233 💬
724 Exenatide 10 micrograms Exenatide 1件: D04121 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
725 Exenatide 5 micrograms Exenatide 1件: D04121 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
726 Exenatide extended release 2mg (bydureon) Exenatide 1件: D04121 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
727 F-18 fpcit - - - - 1件:  6  💬
728 Famotidine Famotidine 1件: D00318 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 4件:  6 , 46, 86, 98 💬
729 Fb-101 - - - - 1件:  6  💬
730 Febuxostat Febuxostat 1件: D01206 💬 1件: XDH 💬 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 3件:  2 ,  6 , 13 💬
731 Ferriprox - - - - 2件:  6 , 120 💬
732 Ferriprox 500 mg - - - - 1件:  6  💬
733 Ferrprox (deferiprone) Deferiprone 1件: D07416 💬 - - 1件:  6  💬
734 Fesoterodine Fesoterodine 1件: D07226 💬 2件: CHRM2, CHRM3 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
735 Fetal porcine cells, neurocell-pd - - - - 1件:  6  💬
736 Filgrastim Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 27件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
737 Finamine tablets - - - - 1件:  6  💬
738 Finasteride Finasteride 1件: D00321 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 1件:  6  💬
739 Fipamezole Fipamezole - - - 2件:  6 , 17 💬
740 Fipamezole hydrochloride Fipamezole - - - 2件:  6 , 17 💬
741 Fipamezole hydrochloride 30 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
742 Fipamezole hydrochloride 60 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
743 Fipamezole hydrochloride 90 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
744 Fipamezole odt Fipamezole - - - 1件:  6  💬
745 Fipamezole odt cohort 2 Fipamezole - - - 1件:  6  💬
746 Flecainide Flecainide 2件: D00638, D07962 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
747 Flecainide acetate Acetate 2件: D00638, D07962 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
748 Flecainidum Flecainide 2件: D00638, D07962 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
749 Florbetaben (18f) - - - - 1件:  6  💬
750 Florbetapir f 18 - - - - 1件:  6  💬
751 Fludrocortisone Fludrocortisone 2件: D00986, D07967 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 3件:  6 , 17, 81 💬
752 Flumazenil Flumazenil 1件: D00697 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 5件:  6 , 13, 17, 18, 206 💬
753 Flutemetamol Flutemetamol - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
754 Flutemetamol f18 Flutemetamol 1件: D10231 💬 - - 5件:  5 ,  6 ,  7 , 17, 127 💬
755 Folic acid Folic acid 1件: D00070 💬 - - 4件:  6 , 46, 49, 84 💬
756 Folic acid, vitamin b6, vitamin b12 Cyanocobalamin 7件: D00070, D00166, D02179, D03615, D03616, D03617, D08454 💬 - - 1件:  6  💬
757 Foliglurax Foliglurax - - - 1件:  6  💬
758 Foliglurax 10 mg (treatment a) Foliglurax - - - 1件:  6  💬
759 Foliglurax 30 mg (treatment b) Foliglurax - - - 1件:  6  💬
760 Foscarbidopa Foscarbidopa - - - 1件:  6  💬
761 Foscarbidopa and foslevodopa Foscarbidopa - - - 1件:  6  💬
762 Foslevodopa - - - - 1件:  6  💬
763 Fpf1100nw - - - - 1件:  6  💬
764 Fpfs-1169 - - - - 1件:  6  💬
765 G-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 16件:  2 ,  6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
766 Gabapentin Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 5件:  6 , 13, 19, 70, 298 💬
767 Gabapentina Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 1件:  6  💬
768 Gabapentina kern pharma Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 1件:  6  💬
769 Galantamine Galantamine 2件: D02173, D04292 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 2件:  6 , 127 💬
770 Ganoderma - - - - 1件:  6  💬
771 Genetic: optional pharmacogenetic assessment - - - - 1件:  6  💬
772 Genz-682452 Venglustat 1件: D11633 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 3件:  6 , 19, 67 💬
773 Genz-682452-au Venglustat 1件: D11633 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 3件:  6 , 19, 67 💬
774 Ghrelin Lenomorelin - - - 3件:  6 , 78, 299 💬
775 Ginkgo Ginkgo biloba - - - 4件:  6 , 13, 18, 90 💬
776 Glial cell line-derived neurotrophic factor - - - - 1件:  6  💬
777 Glial cell line-derived neurotrophic factor (gdnf) - - - - 1件:  6  💬
778 Glucose Dextrose, unspecified form - - - 15件:  2 ,  6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
779 Glutathione Glutathione 2件: D00014, D00031 💬 - - 2件:  6 , 299 💬
780 Glycerol Glycerin 1件: D00028 💬 - - 5件:  6 , 13, 79, 316, 317 💬
781 Glycerol phenylbutyrate Glycerin 3件: D00028, D05868, D10127 💬 - - 1件:  6  💬
782 Glycopyrrolate - - - - 2件:  6 , 34 💬
783 Gm1 ganglioside - - - - 1件:  6  💬
784 Gm608 - - - - 1件:  6  💬
785 Gocovri - - - - 1件:  6  💬
786 Gold Gold - - - 38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
787 Gold nanocrystals Gold - - - 3件:  2 ,  6 , 13 💬
788 Gpi 1485 - - - - 1件:  6  💬
789 Grapefruit Grapefruit - - - 5件:  6 , 46, 50, 83, 97 💬
790 Green tea Green tea leaf 1件: D06903 💬 - - 5件:  6 , 17, 28, 46, 96 💬
791 Green tea polyphenols (egcg/ecg) Epigallocatechin gallate 1件: D06903 💬 - - 1件:  6  💬
792 Grf6021 - - - - 1件:  6  💬
793 Group ad anti-pd + antidepressant - - - - 1件:  6  💬
794 Group r rasagiline Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
795 Group r+ad rasagiline + antidepressant Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
796 Gsh - - - - 2件:  6 , 299 💬
797 Gsk962040 - - - - 1件:  6  💬
798 Gsk962040 (25 mg tablet) - - - - 1件:  6  💬
799 Guar gum Guar gum 1件: D04403 💬 - - 1件:  6  💬
800 Gz/sar402671 - - - - 2件:  6 , 19 💬
801 Hb-admscs Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins - - - 3件:  2 ,  6 , 46 💬
802 Hec122505msoh - - - - 1件:  6  💬
803 Helicobacter pylori eradication therapy - - - - 1件:  6  💬
804 Heptaminol Heptaminol 1件: D07158 💬 - - 1件:  6  💬
805 Heptaminol hydrochloride Heptaminol 1件: D07158 💬 - - 1件:  6  💬
806 Herbal medicinal mixture (roucongrong, heshouwu etc.) Reynoutria multiflora root - - - 1件:  6  💬
807 Hericium erinaceus mycelium - - - - 1件:  6  💬
808 Heshouwu Reynoutria multiflora root - - - 1件:  6  💬
809 Hf0220 - - - - 1件:  6  💬
810 High dose affitope® pd03a + adjuvant - - - - 1件:  6  💬
811 High dose anavex2-73 - - - - 1件:  6  💬
812 High protein. t-diet plus range - - - - 1件:  6  💬
813 Hp-3000 (ropinirole hydrochloride patch) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
814 Hp-3000 placebo - - - - 1件:  6  💬
815 Hp-3000(ropinirole hydrochloride patch) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
816 Human amniotic epithelial stem cells - - - - 1件:  6  💬
817 Human neural stem cell - - - - 1件:  6  💬
818 Human stem cells - - - - 1件:  6  💬
819 Hydrocortisone Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
820 Hydrocortisone cream Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
821 Hydrocortisone cream 1% Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
822 Hydrocortisone cream 10mg/g fna fagron Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
823 Hydrogen Hydrogen - - - 7件:  5 ,  6 , 13, 17, 83, 97, 226 💬
824 Hydrolyzed guar gum Guar gum 1件: D04403 💬 - - 1件:  6  💬
825 I 123 Iodide I-123 - - - 1件:  6  💬
826 I-123 Iodide I-123 - - - 2件:  2 ,  6  💬
827 I-123-5-ia85380 Iodide I-123 - - - 1件:  6  💬
828 I123 - - - - 1件:  6  💬
829 Iberogast - - - - 1件:  6  💬
830 Idebenone Idebenone 1件: D01750 💬 - - 5件:  6 , 13, 18, 113, 302 💬
831 Immediate release carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
832 Immediate release carbidopa/levodopa 10/100 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
833 Immediate release carbidopa/levodopa 25/100 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
834 Impact - - - - 8件:  6 , 13, 46, 50, 53, 96, 97, 299 💬
835 Incobotulinum toxin a - - - - 3件:  2 ,  6 , 13 💬
836 Incobotulinumtoxina Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件:  6  💬
837 Incobotulinumtoxina (100 units) Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件:  6  💬
838 Incobotulinumtoxina (75 units) Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件:  6  💬
839 Infudopa i.v. - - - - 1件:  6  💬
840 Infudopa s.c. - - - - 1件:  6  💬
841 Infusions of young plasma - - - - 1件:  6  💬
842 Inhaled vr040 - - - - 1件:  6  💬
843 Injection of apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
844 Injection of normal saline - - - - 1件:  6  💬
845 Injection of umbilical cord derived mscs - - - - 1件:  6  💬
846 Inosine Inosine 1件: D00054 💬 - - 4件:  2 ,  6 , 13, 17 💬
847 Intracerebral microinjections - - - - 1件:  6  💬
848 Intranasal glutathione - (in)gsh Glutathione 2件: D00014, D00031 💬 - - 1件:  6  💬
849 Intranasal insulin - - - - 2件:  6 , 17 💬
850 Intravenous and oral n-acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 1件:  6  💬
851 Intravenous infusion - - - - 1件:  6  💬
852 Intravenous levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
853 Intravesical injection of botulinum a toxin - - - - 2件:  6 , 17 💬
854 Ioflupane (123i) - - - - 1件:  6  💬
855 Ioflupane 123i (datscan®) - - - - 1件:  6  💬
856 Ioflupane [123 i] - - - - 1件:  6  💬
857 Ioflupane [123i] - - - - 1件:  6  💬
858 Ioflupane i 123 Iodide I-123 1件: D10014 💬 - - 1件:  6  💬
859 Ipratropium Ipratropium 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 86 💬
860 Ipratropium bromide (drug) Ipratropium 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
861 Iproniazid Iproniazid 1件: D02579 💬 2件: MAOA, MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
862 Ips-nsc cells - - - - 1件:  6  💬
863 Ipt803 - - - - 1件:  6  💬
864 Ipx054 100 mg - - - - 1件:  6  💬
865 Ipx054 150 mg - - - - 1件:  6  💬
866 Ipx054 200 mg - - - - 1件:  6  💬
867 Ipx054 250 mg - - - - 1件:  6  💬
868 Ipx054 300 mg - - - - 1件:  6  💬
869 Ipx066 - - - - 1件:  6  💬
870 Ipx066 145 mg - - - - 1件:  6  💬
871 Ipx066 145 mg ld - - - - 1件:  6  💬
872 Ipx066 195 mg - - - - 1件:  6  💬
873 Ipx066 195 mg ld - - - - 1件:  6  💬
874 Ipx066 245 mg - - - - 1件:  6  💬
875 Ipx066 245 mg ld - - - - 1件:  6  💬
876 Ipx066 95 mg - - - - 1件:  6  💬
877 Ipx066 95 mg ld - - - - 1件:  6  💬
878 Ipx066-145 - - - - 1件:  6  💬
879 Ipx066-195 - - - - 1件:  6  💬
880 Ipx066-245 - - - - 1件:  6  💬
881 Ipx066-95 - - - - 1件:  6  💬
882 Ipx203 - - - - 1件:  6  💬
883 Ipx203 140 mg - - - - 1件:  6  💬
884 Ipx203 180 mg - - - - 1件:  6  💬
885 Ipx203 210 mg - - - - 1件:  6  💬
886 Ipx203 270 mg - - - - 1件:  6  💬
887 Ipx203 280 mg - - - - 1件:  6  💬
888 Ipx203 350 mg - - - - 1件:  6  💬
889 Ipx203 er cd-ld - - - - 1件:  6  💬
890 Ir cd-ld - - - - 1件:  6  💬
891 Ir cd-ld (carbidopa-levodopa) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
892 Ir ld / cd - - - - 1件:  6  💬
893 Ir ld/cd - - - - 1件:  6  💬
894 Irl752 - - - - 1件:  6  💬
895 Irl790 - - - - 1件:  6  💬
896 Irx4204 - - - - 1件:  6  💬
897 Isc-hpnsc - - - - 1件:  6  💬
898 Isicom - - - - 1件:  6  💬
899 Isoflurane Isoflurane 1件: D00545 💬 - - 1件:  6  💬
900 Isradipine Isradipine 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
901 Isradipine cr 10mg Isradipine 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
902 Isradipine cr 20mg Isradipine 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
903 Isradipine cr 5mg Isradipine 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
904 Istradefylline Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
905 Istradefylline ( kw-6002) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
906 Istradefylline (kw-6002) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
907 Istradefylline 20 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
908 Istradefylline 20 mg or 40 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
909 Istradefylline 40 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
910 Iti-214 ITI-214 - - - 1件:  6  💬
911 Iv apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
912 Iv levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
913 Izd174 - - - - 2件:  6 , 106 💬
914 Jm - - - - 2件:  6 , 13 💬
915 Jm-010 - - - - 1件:  6  💬
916 Jm-010 group a - - - - 1件:  6  💬
917 Jm-010 group b - - - - 1件:  6  💬
918 Jnj-31001074 - - - - 1件:  6  💬
919 Jnj31-31001074 - - - - 1件:  6  💬
920 Jp 1730 - - - - 1件:  6  💬
921 Jp-1730/f01 - - - - 2件:  6 , 17 💬
922 Jp-1730/f02 - - - - 2件:  6 , 17 💬
923 Jp-1730/f03 - - - - 2件:  6 , 17 💬
924 Jzp-110 - - - - 1件:  6  💬
925 K0706 - - - - 1件:  6  💬
926 Kdt-3594 - - - - 1件:  6  💬
927 Ketone ester drink - - - - 1件:  6  💬
928 Ketone ester elite endurance nutrition drink - - - - 1件:  6  💬
929 Kinoquinone (proposed) - - - - 1件:  6  💬
930 Km-819 - - - - 1件:  6  💬
931 Kw-6002 - - - - 1件:  6  💬
932 Kw-6002 (istradefylline) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
933 Kw-6356 - - - - 1件:  6  💬
934 Kw-6356 high dose - - - - 1件:  6  💬
935 Kw-6356 low dose - - - - 1件:  6  💬
936 Kw-6356 middle dose - - - - 1件:  6  💬
937 Kw-6356 x dose - - - - 1件:  6  💬
938 Kw-6356 y dose - - - - 1件:  6  💬
939 Kw-6500 - - - - 1件:  6  💬
940 L-123 ioflupane - - - - 1件:  6  💬
941 L-3-(3,4-dihydroxyphenyl)alanine Alanine 1件: D00012 💬 - - 1件:  6  💬
942 L-dopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
943 L-dopa/ modopar Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
944 L-dops Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
945 L-methylfolate Levomefolic acid 1件: D09353 💬 - - 1件:  6  💬
946 L-tyrosine Tyrosine 1件: D00022 💬 - - 2件:  6 , 111 💬
947 La - - - - 5件:  6 , 13, 75, 76, 222 💬
948 Lactobacillus casei dg (enterolactis duo®) - - - - 1件:  6  💬
949 Lactobacillus plantarum Lactobacillus plantarum - - - 3件:  6 , 97, 156 💬
950 Lactobacillus plantarum ps128 Lactobacillus plantarum - - - 1件:  6  💬
951 Lactose Lactose 2件: D00046, D03226 💬 - - 6件:  2 ,  6 , 13, 97, 228, 310 💬
952 Lcig - - - - 1件:  6  💬
953 Lcig (duodopa) - - - - 1件:  6  💬
954 Ld / be - - - - 1件:  6  💬
955 Ld+ddci - - - - 1件:  6  💬
956 Ld-ddci - - - - 1件:  6  💬
957 Ld/cd - - - - 1件:  6  💬
958 Leptin Leptin - - - 2件:  6 , 265 💬
959 Leucine Leucine 1件: D00030 💬 - - 10件:  5 ,  6 ,  7 , 19, 96, 97, 127, 283, 284, 299 💬
960 Levetiracetam Levetiracetam 1件: D00709 💬 1件: SV2A 💬 1件: ECM-receptor interaction 4件:  2 ,  4 ,  6 , 13 💬
961 Levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
962 Levodopa (dc.it) (fu) Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
963 Levodopa (delivered intravenously) Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
964 Levodopa (drug), intraduodenal administration Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
965 Levodopa (l-dopa) Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
966 Levodopa (l-dopa) + standard care Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
967 Levodopa / benserazid Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
968 Levodopa / benserazide 200 + 50 mg Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
969 Levodopa 100 mg / benserazide 25 mg Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
970 Levodopa 100 mg a cap Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
971 Levodopa 125 mg a cap Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
972 Levodopa 150 mg a cap Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
973 Levodopa 25mg/100mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
974 Levodopa 75 mg a cap Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
975 Levodopa acute challenge Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
976 Levodopa and carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
977 Levodopa and carbidopa sc solution Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
978 Levodopa and carbidopa solution for sc administration Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
979 Levodopa and decarboxylase inhibitor Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
980 Levodopa and domperidone Domperidone 3件: D00059, D01745, D07868 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
981 Levodopa benserazide madopar Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
982 Levodopa benserazide teva italia Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
983 Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
984 Levodopa carbidopa intestinal gel (lcig) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
985 Levodopa cr (controlled release) Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
986 Levodopa cyclops Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
987 Levodopa dc.it fu Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
988 Levodopa dispersible Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
989 Levodopa infusion Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
990 Levodopa inn Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
991 Levodopa mr Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
992 Levodopa powder for inhalation Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
993 Levodopa tablet Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
994 Levodopa, carbidopa, entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
995 Levodopa, carbidopa, odm-104 Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
996 Levodopa, decarboxylase inhibitor and comt inhibitor Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
997 Levodopa-4'-monophosphate Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
998 Levodopa-carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 2件:  6 , 90 💬
999 Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1000 Levodopa-carbidopa immediate release (lc-ir) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1001 Levodopa-carbidopa intestinal gel Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1002 Levodopa-carbidopa intestinal gel (lcig) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1003 Levodopa-carbidopa multilayer extended release tablet Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1004 Levodopa-carbidopa xl tablet (m) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1005 Levodopa-carbidopa-entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1006 Levodopa/benserazide Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1007 Levodopa/benserazide 100/25 mg Benserazide 2件: D00059, D03082 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1008 Levodopa/benzeraside Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1009 Levodopa/benzerazide Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1010 Levodopa/carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 2件:  6 , 164 💬
1011 Levodopa/carbidopa (ld/cd) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1012 Levodopa/carbidopa (sinemet) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1013 Levodopa/carbidopa 100/25 Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1014 Levodopa/carbidopa hydrate Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1015 Levodopa/carbidopa solution Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1016 Levodopa/carbidopa(200mg/50mg) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1017 Levodopa/carbidopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1018 Levodopa/ddci Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1019 Levodopa/dopa decarboxylase inhibitor Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1020 Liatermin Liatermin 1件: D04727 💬 - - 1件:  6  💬
1021 Liatermin (r-methugdnf) Liatermin 1件: D04727 💬 - - 1件:  6  💬
1022 Lidocaine Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
1023 Lingzhi (ganoderma) - - - - 1件:  6  💬
1024 Lipuro - - - - 1件:  6  💬
1025 Liquigen mct oil - - - - 1件:  6  💬
1026 Liraglutide Liraglutide 1件: D06404 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 3件:  6 , 75, 193 💬
1027 Lisparin - - - - 1件:  6  💬
1028 Lisuride Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 86 💬
1029 Lisuride hydrogenmaleate Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1030 Lisuride transdermal system Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1031 Lisuride tts Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1032 Lisuride tts 10cm² Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1033 Lisuride tts 20cm² Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1034 Lithium - - - - 5件:  2 ,  5 ,  6 ,  7 ,  8  💬
1035 Lixisenatide Lixisenatide 1件: D09729 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
1036 Local anesthesia (lidocaine hydrochloride) Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
1037 Local trade name, 2mg - - - - 1件:  6  💬
1038 Local trade name, 4mg - - - - 1件:  6  💬
1039 Local trade name, 8mg - - - - 1件:  6  💬
1040 Lodalès® - - - - 1件:  6  💬
1041 Lodosyn® - - - - 1件:  6  💬
1042 Lovastatin Lovastatin 1件: D00359 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1043 Low dose affitope® pd03a + adjuvant - - - - 1件:  6  💬
1044 Lu 00-800 - - - - 1件:  6  💬
1045 Lu af28996 - - - - 1件:  6  💬
1046 Lu af82422 - - - - 1件:  6  💬
1047 Lubiprostone Lubiprostone 1件: D04790 💬 1件: CLCN2 💬 1件: Mineral absorption 4件:  6 , 13, 290, 299 💬
1048 Ly03003 - - - - 1件:  6  💬
1049 Ly03003 ( rotigotine, extended-release microspheres) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1050 Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1051 Ly03003( the name of rotigotine) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1052 Ly03003(rotigotine,extended-release microspheres) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1053 Ly03009 f1 - - - - 1件:  6  💬
1054 Ly03009 f2 - - - - 1件:  6  💬
1055 Ly03009 f3 - - - - 1件:  6  💬
1056 Ly03009 f4 - - - - 1件:  6  💬
1057 Ly300164 - - - - 1件:  6  💬
1058 Ly3154207 - - - - 1件:  6  💬
1059 Madopar - - - - 1件:  6  💬
1060 Madopar 125 mg, orodispersible tablet - - - - 1件:  6  💬
1061 Madopar 200+50 mg - - - - 1件:  6  💬
1062 Madopar lt - - - - 1件:  6  💬
1063 Madopar® 125 - - - - 1件:  6  💬
1064 Madopar® 250 - - - - 1件:  6  💬
1065 Madopar® hbs - - - - 1件:  6  💬
1066 Madopar® hbs 125 - - - - 1件:  6  💬
1067 Magnesium Magnesium - - - 16件:  6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
1068 Magnesium oxide Magnesium 1件: D01167 💬 - - 3件:  6 , 166, 291 💬
1069 Maltodextrin Maltodextrin 1件: D02329 💬 - - 4件:  6 , 13, 96, 97 💬
1070 Mannitol Mannitol 1件: D00062 💬 - - 4件:  6 , 60, 96, 299 💬
1071 Mantadix - - - - 1件:  6  💬
1072 Mars - - - - 1件:  6  💬
1073 Masitinib Masitinib 1件: D10229 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
1074 Masitinib mesylate Masitinib 1件: D10229 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
1075 Mavoglurant Mavoglurant - - - 2件:  6 , 206 💬
1076 Mct - - - - 1件:  6  💬
1077 Me2125 (safinamide mesilate) Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1078 Medi1341 - - - - 1件:  6  💬
1079 Melatonin Melatonin 1件: D08170 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 11件:  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
1080 Melatonin pr Melatonin 1件: D08170 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 1件:  6  💬
1081 Melatonin(circadin®) Melatonin 1件: D08170 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 1件:  6  💬
1082 Melevodopa Melevodopa 1件: D07304 💬 - - 1件:  6  💬
1083 Melevodopa and decarboxylase inhibitor Melevodopa 1件: D07304 💬 - - 1件:  6  💬
1084 Melperon - - - - 1件:  6  💬
1085 Melperone Melperone 1件: D07309 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1086 Melperone hcl Melperone 1件: D07309 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1087 Memantin orion - - - - 1件:  6  💬
1088 Memantine Memantine 2件: D04905, D08174 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 7件:  2 ,  6 ,  8 , 13, 49, 127, 205 💬
1089 Memantine (drug) Memantine 2件: D04905, D08174 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
1090 Memantine hydrochloride Memantine 2件: D04905, D08174 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 3件:  2 ,  6 , 127 💬
1091 Mesdopetam Mesdopetam - - - 1件:  6  💬
1092 Mesdopetam (irl790) Mesdopetam - - - 1件:  6  💬
1093 Mesencephalic neuronal precursor cells - - - - 1件:  6  💬
1094 Mesenchymal stem cells - - - - 11件:  2 ,  6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬
1095 Mestinon - - - - 3件:  3 ,  6 , 11 💬
1096 Metabolic cofactor supplementation - - - - 1件:  6  💬
1097 Metformin Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
1098 Methylphenidate Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1099 Methylphenidate (mpd) Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件:  6  💬
1100 Methylphenidate hydrochloride Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 2件:  6 , 13 💬
1101 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
1102 Mg - - - - 3件:  6 , 13, 51 💬
1103 Mid dose anavex2-73 - - - - 1件:  6  💬
1104 Midazolam Midazolam 3件: D00550, D00696, D05028 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 11件:  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 298 💬
1105 Midodrine Midodrine 2件: D01307, D08220 💬 3件: ADRA1A, ADRA1B, ADRA1D 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 3件:  6 , 17, 58 💬
1106 Minocycline Minocycline 2件: D00850, D05045 💬 - - 13件:  2 ,  6 ,  8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬
1107 Minodronic acid Minodronic acid - - - 4件:  6 , 46, 93, 95 💬
1108 Mirabegron Mirabegron 1件: D09535 💬 1件: ADRB3 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 3件:  6 , 13, 226 💬
1109 Mirapex - - - - 1件:  6  💬
1110 Mirapex (pramipexole) Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1111 Mirapex er - - - - 1件:  6  💬
1112 Mirapex la - - - - 1件:  6  💬
1113 Mirapexin - - - - 1件:  6  💬
1114 Mirapexin / sifrol - - - - 1件:  6  💬
1115 Mirapexin extended release various strengths - - - - 1件:  6  💬
1116 Mirapexin*30cpr 0,7mg - - - - 1件:  6  💬
1117 Mirapexin/sifrol - - - - 1件:  6  💬
1118 Mitoq - - - - 3件:  6 , 13, 97 💬
1119 Mk0657 - - - - 1件:  6  💬
1120 Moclobemide Moclobemide 1件: D02561 💬 1件: MAOA 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1121 Modafinil Modafinil 1件: D01832 💬 - - 4件:  6 , 13, 49, 93 💬
1122 Modafinil 50mg Modafinil 1件: D01832 💬 - - 1件:  6  💬
1123 Modal - - - - 5件:  2 ,  6 , 17, 46, 70 💬
1124 Modiodal - - - - 1件:  6  💬
1125 Modopar - - - - 1件:  6  💬
1126 Monoamine oxidase b inhibitors - - - - 1件:  6  💬
1127 Motilium - - - - 2件:  6 , 230 💬
1128 Moxifloxacin Moxifloxacin 2件: D00874, D08237 💬 - - 8件:  2 ,  6 , 46, 49, 85, 86, 240, 299 💬
1129 Moxifloxacin infusion Moxifloxacin 2件: D00874, D08237 💬 - - 1件:  6  💬
1130 Moxifloxacina cloridrato - - - - 1件:  6  💬
1131 Msc - - - - 6件:  6 , 51, 60, 96, 97, 271 💬
1132 Muscimol Muscimol - - - 1件:  6  💬
1133 Mémantine - - - - 1件:  6  💬
1134 N acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 2件:  6 , 19 💬
1135 N-0923 - - - - 1件:  6  💬
1136 N-acetylcysteine Acetylcysteine 1件: D00221 💬 - - 10件:  6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬
1137 N-acetylcysteine capsule Acetylcysteine 1件: D00221 💬 - - 1件:  6  💬
1138 N.a. - - - - 10件:  3 ,  6 ,  8 , 13, 46, 96, 97, 240, 256, 271 💬
1139 N04bd02 - - - - 1件:  6  💬
1140 Nabilone Nabilone 1件: D05099 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 2件:  6 , 13 💬
1141 Nabilone 0.25 mg Nabilone 1件: D05099 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 1件:  6  💬
1142 Nacom - - - - 1件:  6  💬
1143 Nacom 100 - - - - 1件:  6  💬
1144 Nacom levodopa+cardidopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1145 Nal - - - - 2件:  6 , 299 💬
1146 Nalmefene Nalmefene 1件: D05111 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1147 Naloxone Naloxone 2件: D01340, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 2件:  6 , 226 💬
1148 Naloxone hydrochloride dihydrate Naloxone 2件: D01340, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1149 Naltrexone Naltrexone 2件: D02095, D05113 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 12件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
1150 Nardil - - - - 1件:  6  💬
1151 Nbtx-001 - - - - 1件:  6  💬
1152 Nd0611 - - - - 1件:  6  💬
1153 Nd0612 - - - - 1件:  6  💬
1154 Nd0612 (levodopa/carbidopa solution) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1155 Nd1421 - - - - 1件:  6  💬
1156 Nd1587 - - - - 1件:  6  💬
1157 Nd1589 - - - - 1件:  6  💬
1158 Nd1590 - - - - 1件:  6  💬
1159 Nd1702 - - - - 1件:  6  💬
1160 Nebicapone Nebicapone - - - 1件:  6  💬
1161 Nelotanserin Nelotanserin 1件: D09645 💬 1件: HTR2A 💬 5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
1162 Neridronic acid Neridronic Acid - - - 1件:  6  💬
1163 Nerixia*im ev 1f 25mg - - - - 1件:  6  💬
1164 Neu-120 - - - - 1件:  6  💬
1165 Neupro - - - - 1件:  6  💬
1166 Neupro (reference) - - - - 1件:  6  💬
1167 Neupro 2 mg/24 h parche transdérmico - - - - 1件:  6  💬
1168 Neupro 2 mg/24 h transdermal patch - - - - 1件:  6  💬
1169 Neupro 2mg/24 h transdermal patch - - - - 1件:  6  💬
1170 Neupro 2mg/24h transdermal patch - - - - 1件:  6  💬
1171 Neupro 4 mg/24 h parche transdérmico - - - - 1件:  6  💬
1172 Neupro 4 mg/24 h transdermal patch - - - - 1件:  6  💬
1173 Neupro 4mg/24 h transdermal patch - - - - 1件:  6  💬
1174 Neupro 4mg/24h transdermal patch - - - - 1件:  6  💬
1175 Neupro 4mg/24hr transdermal patch - - - - 1件:  6  💬
1176 Neupro 6 mg/24 h parche transdérmico - - - - 1件:  6  💬
1177 Neupro 6 mg/24 h transdermal patch - - - - 1件:  6  💬
1178 Neupro 6mg/24 h transdermal patch - - - - 1件:  6  💬
1179 Neupro 6mg/24h transdermal patch - - - - 1件:  6  💬
1180 Neupro 8 mg/24 h parche transdérmico - - - - 1件:  6  💬
1181 Neupro 8 mg/24 h transdermal patch - - - - 1件:  6  💬
1182 Neupro 8mg/24h transdermal patch - - - - 1件:  6  💬
1183 Neupro*28cer 2mg/24h - - - - 1件:  6  💬
1184 Neupro*28cer 4mg/24h - - - - 1件:  6  💬
1185 Neupro*28cer 6mg/24h - - - - 1件:  6  💬
1186 Neupro*28cer 8mg/24h - - - - 1件:  6  💬
1187 Neupro*7cer 4mg/24h - - - - 1件:  6  💬
1188 Neupro*7cer 6mg/24h - - - - 1件:  6  💬
1189 Neupro*7cer 8mg/24h - - - - 1件:  6  💬
1190 Neupro® - - - - 1件:  6  💬
1191 Neuraceq - - - - 1件:  6  💬
1192 Neurobloc - - - - 1件:  6  💬
1193 Neuroepo - - - - 1件:  6  💬
1194 Neurohormonal mechanisms - - - - 2件:  6 , 127 💬
1195 Neurpro - - - - 1件:  6  💬
1196 Niacin Niacin 1件: D00049 💬 - - 3件:  6 , 78, 265 💬
1197 Niacinamide Nicotinamide 1件: D00036 💬 - - 4件:  5 ,  6 , 13, 67 💬
1198 Nicorette 10mg/ 16 h - - - - 1件:  6  💬
1199 Nicorette 15 mg/ 16 h - - - - 1件:  6  💬
1200 Nicorette 5 mg/ 16 h - - - - 1件:  6  💬
1201 Nicotinamide Nicotinamide 1件: D00036 💬 - - 6件:  2 ,  6 , 18, 49, 162, 191 💬
1202 Nicotinamide riboside Nicotinamide 1件: D00036 💬 - - 4件:  2 ,  6 , 18, 191 💬
1203 Nicotine Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 2件:  6 , 84 💬
1204 Nicotine gum Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 1件:  6  💬
1205 Nicotine nasal spray 10 mg/ml (0.5 mg/spray) Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 1件:  6  💬
1206 Nicotine patch Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 2件:  6 , 84 💬
1207 Nicotine transdermal patch Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 1件:  6  💬
1208 Nicotinell - - - - 1件:  6  💬
1209 Nicotinell 17,5 mg/24-stunden-pflaster - - - - 1件:  6  💬
1210 Nicotinell 35 mg/24-stunden-pflaster - - - - 1件:  6  💬
1211 Nilotinib Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 5件:  6 ,  8 , 34, 51, 86 💬
1212 Nilotinib 150mg oral capsule [tasigna] Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
1213 Nilotinib 300mg oral capsule [tasigna] Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
1214 Nitrogen Nitrogen 1件: D00083 💬 - - 6件:  5 ,  6 , 17, 171, 211, 299 💬
1215 Nly01 - - - - 1件:  6  💬
1216 Nmda Ketamine 2件: D00711, D08098 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
1217 Normal saline - - - - 16件:  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬
1218 Northera - - - - 1件:  6  💬
1219 Nortriptyline Nortriptyline 2件: D00816, D08288 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 226 💬
1220 Nortriptyline hydrochloride Nortriptyline 2件: D00816, D08288 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
1221 Npc transplantation - - - - 1件:  6  💬
1222 Nr2b nmda antagonist cp-101,606 (traxoprodil) Ketamine 2件: D00711, D08098 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
1223 Ns 2330 - - - - 1件:  6  💬
1224 Ns2330 - - - - 1件:  6  💬
1225 Nt 101 - - - - 4件:  5 ,  6 ,  7 , 17 💬
1226 Ntcell implantation - - - - 1件:  6  💬
1227 Null - - - - 16件:  6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
1228 Nw-1015 - - - - 1件:  6  💬
1229 Nw-1015e, emd 1195686, msc2191632b - - - - 1件:  6  💬
1230 Nyx-458 - - - - 1件:  6  💬
1231 Oc oral solution treatment a - - - - 1件:  6  💬
1232 Oc oral solution treatment b - - - - 1件:  6  💬
1233 Oc oral solution treatment c - - - - 1件:  6  💬
1234 Oc oral solution treatment d - - - - 1件:  6  💬
1235 Odm-101 - - - - 1件:  6  💬
1236 Odm-101 105mg carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1237 Odm-101 65mg carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1238 Odm-104 - - - - 1件:  6  💬
1239 Omeprazole Omeprazole 4件: D00455, D01207, D05259, D05261 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 16件:  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
1240 Onabotulinumtoxin a injection - - - - 1件:  6  💬
1241 Onabotulinumtoxina Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 3件:  6 , 13, 226 💬
1242 Ondansetron Ondansetron 2件: D00456, D00678 💬 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 2件: Serotonergic synapse, Taste transduction 3件:  6 , 97, 231 💬
1243 Ondansetron 8 mg film-coated tablets Ondansetron 2件: D00456, D00678 💬 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 2件: Serotonergic synapse, Taste transduction 1件:  6  💬
1244 Ondansetron hydrochloride dihydrate Ondansetron 2件: D00456, D00678 💬 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 2件: Serotonergic synapse, Taste transduction 2件:  6 , 97 💬
1245 Ongentys - - - - 1件:  6  💬
1246 Ono-2160/cd - - - - 1件:  6  💬
1247 Ono-2370 - - - - 1件:  6  💬
1248 Ono-2506po - - - - 2件:  2 ,  6  💬
1249 Opc - - - - 1件:  6  💬
1250 Opicapone Opicapone 1件: D10825 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1251 Opicapone (opc) Opicapone 1件: D10825 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1252 Optimal drug therapy - - - - 1件:  6  💬
1253 Optimized antiparkinsonian treatment - - - - 1件:  6  💬
1254 Oral escitalopram Escitalopram 3件: D02567, D07704, D07913 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
1255 Oral levodopa and carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1256 Oral levodopa/carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1257 Orally disintegrating selegiline (zelapar) Selegiline 2件: D00785, D03731 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1258 Osu 6162 similar to (-)-osu 6162 - - - - 1件:  6  💬
1259 Osu6162 similar to (-)-osu 6162 - - - - 2件:  6 ,  8  💬
1260 Other nervous system drugs - - - - 2件:  6 , 13 💬
1261 Other parkinson's disease treatments - - - - 1件:  6  💬
1262 Other: [11c]donepezil pet Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1263 Other: balance Isoxaflutole - - - 3件:  6 , 13, 299 💬
1264 Other: balance exercise Isoxaflutole - - - 1件:  6  💬
1265 Other: balance training Isoxaflutole - - - 2件:  6 , 13 💬
1266 Other: berg balance scale Isoxaflutole - - - 2件:  6 , 13 💬
1267 Other: best medical treatment - - - - 1件:  6  💬
1268 Other: collection of csf, blood, urine, saliva - - - - 1件:  6  💬
1269 Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease Isoxaflutole - - - 1件:  6  💬
1270 Other: control - - - - 8件:  6 , 19, 70, 75, 85, 97, 162, 193 💬
1271 Other: controlled environment tests (series of tasks of everyday life) - - - - 1件:  6  💬
1272 Other: controls primary cervical dystonia (trihexyphenidyl) Trihexyphenidyl 2件: D00787, D08638 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
1273 Other: data capture Bifenthrin - - - 1件:  6  💬
1274 Other: diary completion - - - - 1件:  6  💬
1275 Other: dyt 1 dystonia - - - - 1件:  6  💬
1276 Other: dyt 1 dystonia (healthy control) - - - - 1件:  6  💬
1277 Other: endurance - - - - 1件:  6  💬
1278 Other: evaluation by investigator - - - - 1件:  6  💬
1279 Other: event-related evoked potential using electroencephalography (eeg). - - - - 1件:  6  💬
1280 Other: fog - - - - 1件:  6  💬
1281 Other: four square step test - - - - 2件:  6 , 13 💬
1282 Other: functional mobility - - - - 2件:  6 , 13 💬
1283 Other: functional reach test - - - - 2件:  6 , 13 💬
1284 Other: gait and balance group training Isoxaflutole - - - 1件:  6  💬
1285 Other: hemicellulose crystalline - - - - 1件:  6  💬
1286 Other: high intensity exercise and balance training Isoxaflutole - - - 1件:  6  💬
1287 Other: hoehn and yahr scale - - - - 1件:  6  💬
1288 Other: imitation surgical procedure (isp) - - - - 1件:  6  💬
1289 Other: lower limb strength - - - - 1件:  6  💬
1290 Other: mibg label with i123 or i124 - - - - 1件:  6  💬
1291 Other: mobile platform exercise - - - - 1件:  6  💬
1292 Other: motor assessments before taking regular pd treatment - - - - 1件:  6  💬
1293 Other: motor assessments on regular pd treatment - - - - 1件:  6  💬
1294 Other: mp+ddci - - - - 1件:  6  💬
1295 Other: mp-equivalent - - - - 1件:  6  💬
1296 Other: mp-low - - - - 1件:  6  💬
1297 Other: mri - - - - 3件:  6 , 127, 206 💬
1298 Other: multidisciplinary intensive rehabilitation treatment - - - - 1件:  6  💬
1299 Other: music - - - - 1件:  6  💬
1300 Other: neupro 4 mg / 24 hr. transdermal patch - - - - 1件:  6  💬
1301 Other: non-motor symptoms - - - - 1件:  6  💬
1302 Other: nordic walking (only osteoporosis group) - - - - 1件:  6  💬
1303 Other: observational cohort - - - - 1件:  6  💬
1304 Other: optional blood-oxygen-level dependent functionalmri Oxygen 1件: D00003 💬 - - 1件:  6  💬
1305 Other: parkinson mpower mobile application - - - - 1件:  6  💬
1306 Other: pd exercise intervention - - - - 1件:  6  💬
1307 Other: pd vitamin + exercise - - - - 1件:  6  💬
1308 Other: physical function performance test - - - - 1件:  6  💬
1309 Other: physical therapy - - - - 2件:  6 , 70 💬
1310 Other: pittsburgh compound b [11c]-pib Pittsburgh Compound B - - - 1件:  6  💬
1311 Other: questionnaires - - - - 5件:  6 , 13, 41, 93, 96 💬
1312 Other: recommendation with regard to nutrition - - - - 1件:  6  💬
1313 Other: rhythmic auditory stimulation (ras) - - - - 2件:  6 , 13 💬
1314 Other: rhythmic balance-movement training (rbmt) Isoxaflutole - - - 1件:  6  💬
1315 Other: rotigotine Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1316 Other: saline - - - - 8件:  2 ,  6 , 46, 97, 98, 256, 274, 301 💬
1317 Other: screening to prevent falls - - - - 1件:  6  💬
1318 Other: sham group - - - - 1件:  6  💬
1319 Other: sham surgery - - - - 1件:  6  💬
1320 Other: smartphone-based balance exercises Isoxaflutole - - - 1件:  6  💬
1321 Other: specific sl-therapy - - - - 1件:  6  💬
1322 Other: standardized scales: mds-updrs (part ii to iv) and rdrs - - - - 1件:  6  💬
1323 Other: stool sample - - - - 2件:  6 , 299 💬
1324 Other: t-dcs group - - - - 1件:  6  💬
1325 Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale Isoxaflutole - - - 1件:  6  💬
1326 Other: the timed 360° turn test - - - - 1件:  6  💬
1327 Other: timed up and go test - - - - 1件:  6  💬
1328 Other: trunk impairment scale - - - - 1件:  6  💬
1329 Other: tyramine Tyramine - - - 1件:  6  💬
1330 Other: unified parkinson's disease rating scale - - - - 1件:  6  💬
1331 Other: usual care arm exercise - - - - 1件:  6  💬
1332 Other: usual drug treatment of parkinson's disease - - - - 1件:  6  💬
1333 Other: voluntary cough test - - - - 1件:  6  💬
1334 Over-encapsulated entacapone tablets Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1335 Over-encapsulated modafinil Modafinil 1件: D01832 💬 - - 1件:  6  💬
1336 Oxaloacetate (oaa) - - - - 1件:  6  💬
1337 Oxb-102 - - - - 1件:  6  💬
1338 Oxn 10 mg / 5 mg pr - - - - 1件:  6  💬
1339 Oxn 20 mg / 10 mg pr - - - - 1件:  6  💬
1340 Oxn 5 mg/2.5 mg pr - - - - 1件:  6  💬
1341 Oxybate gamma-Hydroxybutyric acid - - - 2件:  6 , 149 💬
1342 Oxybuprocaine Oxybuprocaine 2件: D01768, D08319 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
1343 Oxybutynin Oxybutynin 2件: D00465, D00722 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 13 💬
1344 Oxybutynin and darifenacin Darifenacin 4件: D00465, D00722, D01699, D03654 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
1345 Oxybutynin hydrochloride Oxybutynin 2件: D00465, D00722 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 13 💬
1346 Oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 7件:  6 , 13, 46, 70, 226, 231, 298 💬
1347 Oxycodone hydrochloride Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 4件:  6 , 70, 226, 298 💬
1348 Oxycodone/naloxone prolonged release tablets Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1349 Oxycodone/naloxone prolonged release tablets 10 mg /5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1350 Oxycodone/naloxone prolonged release tablets 20 mg /10 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1351 Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg Naloxone 5件: D01340, D03783, D05312, D05462, D08249 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1352 Oxygen Oxygen 1件: D00003 💬 - - 18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
1353 Oxytocin Oxytocin 1件: D00089 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 5件:  6 , 127, 193, 206, 226 💬
1354 Oxytocin synthetic Oxytocin 1件: D00089 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 1件:  6  💬
1355 P2b001 - - - - 1件:  6  💬
1356 P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), Pramipexole 5件: D00559, D02562, D05575, D08469, D10829 💬 4件: DRD2, DRD3, DRD4, MAOB 💬 18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1357 P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), Pramipexole 5件: D00559, D02562, D05575, D08469, D10829 💬 4件: DRD2, DRD3, DRD4, MAOB 💬 18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1358 Paracetamol Acetaminophen 1件: D00217 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 5件:  3 ,  6 , 13, 35, 46 💬
1359 Parapres - - - - 1件:  6  💬
1360 Parcopa - - - - 1件:  6  💬
1361 Pardaprunox - - - - 1件:  6  💬
1362 Pardoprunox Pardoprunox 1件: D09397 💬 3件: DRD2, DRD3, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
1363 Pardoprunox hydrochloride Pardoprunox 1件: D09397 💬 3件: DRD2, DRD3, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
1364 Paroxetine Paroxetine 4件: D02260, D02362, D05374, D05375 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 3件:  6 , 13, 46 💬
1365 Part 1, jm-010 component group a - - - - 1件:  6  💬
1366 Part 1, jm-010 component group b - - - - 1件:  6  💬
1367 Part 1, jm-010 component group c - - - - 1件:  6  💬
1368 Part 2, jm-010 combination group a - - - - 1件:  6  💬
1369 Part 2, jm-010 combination group b - - - - 1件:  6  💬
1370 Part 2, jm-010 component group c - - - - 1件:  6  💬
1371 Pat - - - - 3件:  6 , 13, 160 💬
1372 Pbf-509 - - - - 1件:  6  💬
1373 Pd patients h&y=1.5-2 medications off - - - - 1件:  6  💬
1374 Pd patients h&y=1.5-2 medications on - - - - 1件:  6  💬
1375 Pd patients h&y=3 medications off - - - - 1件:  6  💬
1376 Pd patients h&y=3 medications on - - - - 1件:  6  💬
1377 Pd vitamin supplementation - - - - 1件:  6  💬
1378 Peg - - - - 9件:  6 , 13, 46, 65, 78, 96, 97, 240, 299 💬
1379 Perampanel Perampanel 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 3件:  2 ,  6 , 144 💬
1380 Pergolide Pergolide 2件: D00502, D08339 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1381 Pet - - - - 1件:  6  💬
1382 Pf-06412562 - - - - 1件:  6  💬
1383 Pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1384 Pf-06649751 - 15mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1385 Pf-06649751 - 1mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1386 Pf-06649751 - 5mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1387 Pf-06649751 high dose (15 mg qd) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1388 Pf-06649751 low dose (1 mg qd) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1389 Pf-06649751 middle dose 1 (3 mg qd) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1390 Pf-06649751 middle dose 2 (7 mg qd) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1391 Pf-06669571 - - - - 1件:  6  💬
1392 Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid Propanoic acid 1件: D02310 💬 - - 1件:  6  💬
1393 Ph. eur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid - - - - 1件:  6  💬
1394 Phenlarmide tablets - - - - 1件:  6  💬
1395 Phenylbutyrate Phenylbutyric acid 1件: D05868 💬 - - 11件:  2 ,  3 ,  6 ,  8 , 15, 93, 94, 244, 251, 297, 299 💬
1396 Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid Propanoic acid 1件: D02310 💬 - - 1件:  6  💬
1397 Pheur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid - - - - 1件:  6  💬
1398 Piclozotan Piclozotan - - - 1件:  6  💬
1399 Pilocarpine Pilocarpine 3件: D00525, D02200, D05478 💬 2件: CHRM2, CHRM3 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 3件:  6 , 53, 299 💬
1400 Pimavanserin Pimavanserin - - - 1件:  6  💬
1401 Pimavanserin (acp-103) Pimavanserin - - - 1件:  6  💬
1402 Pimavanserin tartrate Pimavanserin - - - 1件:  6  💬
1403 Pimavanserin tartrate (acp-103) Pimavanserin - - - 1件:  6  💬
1404 Pioglitazone Pioglitazone 2件: D00945, D08378 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1405 Piribedil Piribedil 1件: D07305 💬 2件: DRD2, DRD3 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1406 Piribedil (clarium) Piribedil 1件: D07305 💬 2件: DRD2, DRD3 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1407 Pitolisant Pitolisant 1件: D10749 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 2件:  6 , 193 💬
1408 Pittsburgh compound b Pittsburgh Compound B - - - 2件:  6 , 127 💬
1409 Pk-merz - - - - 1件:  6  💬
1410 Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
1411 Placebo - - - - 26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
1412 Plantago ovata husk - - - - 1件:  6  💬
1413 Posiphen Posiphen - - - 1件:  6  💬
1414 Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) Activated charcoal 1件: D03251 💬 - - 1件:  6  💬
1415 Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) - - - - 1件:  6  💬
1416 Pr oxycodone Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1417 Pr001a - - - - 1件:  6  💬
1418 Pramipexol Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1419 Pramipexol extended release Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1420 Pramipexol immediate release Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1421 Pramipexole Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件:  2 ,  6  💬
1422 Pramipexole 0.125 mg tablets Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1423 Pramipexole 0.5 mg tablets Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1424 Pramipexole dihydrochloride Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1425 Pramipexole dihydrochloride extended-release tablets Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1426 Pramipexole dihydrochloride monohydrate Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1427 Pramipexole dihydrochloride monohydrate extended release Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1428 Pramipexole er Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1429 Pramipexole extended release Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1430 Pramipexole extended release tablet Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1431 Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole) Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1432 Pramipexole immediate release Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1433 Pramipexole immediate release tablet Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1434 Pramipexole ir Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1435 Pramipexole or ropinirole Pramipexole 4件: D00559, D00784, D05575, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1436 Pramipexole sr Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1437 Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride) Pramipexole 2件: D00559, D05575 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1438 Prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
1439 Preladenant Preladenant 1件: D09717 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1440 Preladenant 10 mg tablet Preladenant 1件: D09717 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1441 Preladenant 2 mg tablet Preladenant 1件: D09717 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1442 Preladenant 5 mg tablet Preladenant 1件: D09717 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1443 Premarin ® - - - - 1件:  6  💬
1444 Pridia (donepezil hydrochloride) 5mg Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1445 Pridia 10mg - - - - 1件:  6  💬
1446 Pridia 5mg - - - - 1件:  6  💬
1447 Pridopidine Pridopidine 1件: D09953 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  2 ,  6 ,  8  💬
1448 Prim-dj2727 - - - - 2件:  6 , 97 💬
1449 Primary cervical dystonia (trihexyphenidyl) Trihexyphenidyl 2件: D00787, D08638 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
1450 Primavanserin tartrate - - - - 1件:  6  💬
1451 Prior donepezil 5mg Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1452 Prior donzepezil 10mg - - - - 1件:  6  💬
1453 Probiotic - - - - 7件:  2 ,  6 , 93, 96, 97, 193, 266 💬
1454 Probiotic capsule - - - - 1件:  6  💬
1455 Probiotics with prebiotic - - - - 1件:  6  💬
1456 Procedure: [123i]-ibzm imaging - - - - 1件:  6  💬
1457 Procedure: [123i]beta-cit and spect imaging - - - - 1件:  6  💬
1458 Procedure: [123i]ß-cit and spect imaging - - - - 1件:  6  💬
1459 Procedure: biofluid samplings - - - - 1件:  6  💬
1460 Procedure: blood analysis - - - - 1件:  6  💬
1461 Procedure: blood draw - - - - 5件:  6 , 19, 65, 231, 299 💬
1462 Procedure: cardiac monitoring - - - - 1件:  6  💬
1463 Procedure: datscan and spect imaging - - - - 1件:  6  💬
1464 Procedure: electroacupuncture - - - - 2件:  6 , 70 💬
1465 Procedure: embryonic dopamine cell implant surgery Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1466 Procedure: exergame - - - - 2件:  6 , 13 💬
1467 Procedure: fluoroscopic swallow evaluation - - - - 1件:  6  💬
1468 Procedure: home based balance training Isoxaflutole - - - 2件:  6 , 13 💬
1469 Procedure: lumbar puncture - - - - 5件:  6 , 13, 19, 96, 97 💬
1470 Procedure: meg - - - - 1件:  6  💬
1471 Procedure: motion analysis - - - - 1件:  6  💬
1472 Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j) - - - - 1件:  6  💬
1473 Procedure: pet/ct - - - - 1件:  6  💬
1474 Procedure: physical exam and updrs part iii assessment - - - - 1件:  6  💬
1475 Procedure: sedation with iv propofol Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1476 Procedure: sham surgery - - - - 1件:  6  💬
1477 Procedure: static, dynamic and functional balance exercises Isoxaflutole - - - 1件:  6  💬
1478 Procedure: static, dynamic and functional balance exercises with dual task Isoxaflutole - - - 1件:  6  💬
1479 Procedure: tissue samplings - - - - 1件:  6  💬
1480 Procedure: umbilical cord blood therapy Umbilical Cord Blood Hematopoietic Stem Cells - - - 2件:  2 ,  6  💬
1481 Prolonged release tablet - - - - 1件:  6  💬
1482 Prolopa® - - - - 1件:  6  💬
1483 Propanoic acid Propanoic acid 1件: D02310 💬 - - 2件:  6 , 271 💬
1484 Propofol Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 8件:  6 , 21, 22, 34, 46, 84, 98, 296 💬
1485 Propofol-lipuro Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1486 Propranolol Propranolol 2件: D00483, D08443 💬 3件: ADRB1, ADRB2, ADRB3 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 158, 167, 227, 278 💬
1487 Propranolol hcl cf 40 mg tablet Propranolol 2件: D00483, D08443 💬 3件: ADRB1, ADRB2, ADRB3 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1488 Prosavin - - - - 1件:  6  💬
1489 Proscar*30cpr riv 5mg - - - - 1件:  6  💬
1490 Prx002 - - - - 1件:  6  💬
1491 Prx002, elt2, anti-alpha-synuclein monoclonal antibody - - - - 1件:  6  💬
1492 Pt320 2.0 mg - - - - 1件:  6  💬
1493 Pt320 2.5 mg - - - - 1件:  6  💬
1494 Pxt002331 - - - - 1件:  6  💬
1495 Pxt002331 - 20mg - - - - 1件:  6  💬
1496 Pxt002331 - dose 1 - - - - 1件:  6  💬
1497 Pxt002331 - dose 2 - - - - 1件:  6  💬
1498 Pym50028 - - - - 1件:  6  💬
1499 Pyridostigmine Pyridostigmine 1件: D00487 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 4件:  3 ,  6 , 11, 256 💬
1500 Pyridostigmine bromide Pyridostigmine 1件: D00487 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  3 ,  6 , 256 💬
1501 Quetiapine Quetiapine 2件: D00458, D08456 💬 2件: DRD2, HTR2A 💬 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 2件:  6 , 13 💬
1502 R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride Benzofuran - - - 1件:  6  💬
1503 R-methugdnf Liatermin 1件: D04727 💬 - - 1件:  6  💬
1504 Raav-gad - - - - 1件:  6  💬
1505 Raclopride Raclopride - - - 4件:  5 ,  6 ,  7 , 17 💬
1506 Racol - - - - 3件:  6 , 96, 291 💬
1507 Radiation: [18-fluorine] flubatine pet scan - - - - 1件:  6  💬
1508 Radiation: fluoroscopy - - - - 1件:  6  💬
1509 Radiation: h215o pet - - - - 2件:  6 , 17 💬
1510 Radiation: pet with the tracer 11c-pe2i - - - - 1件:  6  💬
1511 Radiation: pet with the tracer 18f-dpa-714 - - - - 1件:  6  💬
1512 Radiation: radiosurgical thalamotomy - - - - 1件:  6  💬
1513 Radiation: videofluoroscopic swallow evaluation - - - - 1件:  6  💬
1514 Ramelteon Ramelteon 1件: D02689 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 3件:  6 ,  8 , 46 💬
1515 Ras - - - - 3件:  6 , 13, 66 💬
1516 Rasagilin - - - - 2件:  5 ,  6  💬
1517 Rasagilina Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
1518 Rasagilina mesilato Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
1519 Rasagilina mesilato (12 weeks) Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1520 Rasagiline Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 4件:  2 ,  5 ,  6 , 17 💬
1521 Rasagiline 1 mg capsule Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1522 Rasagiline 1mg tablet Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1523 Rasagiline 2 mg tablet Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1524 Rasagiline mesilate Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 3件:  2 ,  5 ,  6  💬
1525 Rasagiline mesylate Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
1526 Rasagiline mesylate 1.0 mg Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1527 Rasagiline mesylate plus mirapex Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1528 Rasagiline mesylate with levodopa Levodopa 4件: D00059, D02562, D08469, D10829 💬 6件: DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1529 Rasagiline mesylate with requip Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1530 Rasagiline tablets Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1531 Recombinant human cerebral dopamine neurotrophic factor Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1532 Recombinant-methionyl human glial cell line-derived neurotrophic factor - - - - 1件:  6  💬
1533 Reduced glutathione Glutathione 2件: D00014, D00031 💬 - - 2件:  6 , 299 💬
1534 Reduced glutathione 100mg Glutathione 2件: D00014, D00031 💬 - - 1件:  6  💬
1535 Reduced glutathione 200mg Glutathione 2件: D00014, D00031 💬 - - 1件:  6  💬
1536 Regular novolin r - - - - 1件:  6  💬
1537 Remifentanil Remifentanil 2件: D01177, D08473 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 2件:  6 , 70 💬
1538 Remifentanyl Remifentanil 2件: D01177, D08473 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件:  6  💬
1539 Reminyl - - - - 1件:  6  💬
1540 Reminyl retard - - - - 1件:  6  💬
1541 Repaglinide Repaglinide 1件: D00594 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 3件:  6 , 21, 299 💬
1542 Requip - - - - 2件:  6 , 309 💬
1543 Requip 21 cpr 0,25 mg - - - - 1件:  6  💬
1544 Requip 21 cpr 0,5 mg - - - - 1件:  6  💬
1545 Requip 21 cpr 1 mg - - - - 1件:  6  💬
1546 Requip 21 cpr 2 mg - - - - 1件:  6  💬
1547 Requip cr - - - - 2件:  2 ,  6  💬
1548 Requip modutab, 2mg - - - - 1件:  6  💬
1549 Requip modutab, 4mg - - - - 1件:  6  💬
1550 Requip modutab, 8mg - - - - 1件:  6  💬
1551 Requip pr - - - - 1件:  6  💬
1552 Requip prolonged release - - - - 1件:  6  💬
1553 Requip xl prolonged-release - - - - 1件:  6  💬
1554 Requip*21cpr 0,25mg - - - - 1件:  6  💬
1555 Requip*21cpr 0,5mg - - - - 1件:  6  💬
1556 Requip*21cpr 1mg - - - - 1件:  6  💬
1557 Requip*21cpr 5mg - - - - 1件:  6  💬
1558 Requip*28cpr 8mg r.p. - - - - 1件:  6  💬
1559 Requip-lp - - - - 1件:  6  💬
1560 Requip-modutab - - - - 1件:  6  💬
1561 Requip-modutab , 2mg - - - - 1件:  6  💬
1562 Requip-modutab , 4mg - - - - 1件:  6  💬
1563 Requip-modutab , 8mg - - - - 1件:  6  💬
1564 Requip-modutab, 2mg - - - - 1件:  6  💬
1565 Requip-modutab, 4mg - - - - 1件:  6  💬
1566 Requip-modutab, 8mg - - - - 1件:  6  💬
1567 Resistant maltodextrin Maltodextrin 1件: D02329 💬 - - 1件:  6  💬
1568 Resistant starch - - - - 1件:  6  💬
1569 Restex tabletten - - - - 1件:  6  💬
1570 Rifampicin Rifampicin 1件: D00211 💬 - - 5件:  6 , 17, 46, 93, 299 💬
1571 Rifampin Rifampicin 1件: D00211 💬 - - 5件:  6 , 13, 84, 86, 299 💬
1572 Rifampin 300mg bid + istradefylline 40mg day 8 only Istradefylline 2件: D00211, D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1573 Rifaximin Rifaximin 1件: D02554 💬 - - 6件:  6 , 65, 96, 97, 99, 296 💬
1574 Rifaximin 550 mg Rifaximin 1件: D02554 💬 - - 1件:  6  💬
1575 Ritalin - - - - 2件:  6 , 13 💬
1576 Riv-tds 13.3 mg/24 h - - - - 1件:  6  💬
1577 Rivastigmin luye transdermal patches - 4.6mg/24h - - - - 1件:  6  💬
1578 Rivastigmine Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  5 ,  6 , 13 💬
1579 Rivastigmine capsule Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1580 Rivastigmine cf Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1581 Rivastigmine luye transdermal patch- 9.5mg/24h Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1582 Rivastigmine patch 9.5 cm2 Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1583 Rivastigmine transdermal patch Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 2件:  6 , 13 💬
1584 Rivastigmine transdermal system Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1585 Rivastigmine transdermal system 13.3 mg/24 h Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
1586 Rm-131 - - - - 1件:  6  💬
1587 Ro - - - - 1件:  6  💬
1588 Ro7046015 - - - - 1件:  6  💬
1589 Rop - - - - 1件:  6  💬
1590 Rop+l-dopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1591 Ropinirole Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 , 74, 309 💬
1592 Ropinirole (as hydrochloride) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1593 Ropinirole controlled-release (requip cr) for rls Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1594 Ropinirole cr 2mg tablet Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1595 Ropinirole cr 8mg tablet Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1596 Ropinirole hydrochloride Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 309 💬
1597 Ropinirole hydrochloride extended-release tablet Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1598 Ropinirole hydrochloride extended-release tablet placebo Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1599 Ropinirole hydrochloride prolonged release Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1600 Ropinirole immediate release Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1601 Ropinirole implant Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1602 Ropinirole ir Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1603 Ropinirole ir tablets Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1604 Ropinirole monotherapy Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1605 Ropinirole oral product Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1606 Ropinirole pr Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1607 Ropinirole pr, 2mg Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1608 Ropinirole pr/xr Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1609 Ropinirole pr/xr tablets Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1610 Ropinirole prolonged release Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1611 Ropinirole prolonged release/extended release(pr/xr) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1612 Ropinirole xl Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1613 Ropinirole xl (formerly cr) Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1614 Ropinirole/l-dopa Levodopa 3件: D00059, D00784, D08489 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1615 Rosuvastatin Rosuvastatin 2件: D01915, D08492 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 11件:  6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
1616 Rotigotin - - - - 1件:  6  💬
1617 Rotigotina Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1618 Rotigotine Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1619 Rotigotine (reference product pr 2.1.1) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1620 Rotigotine (test product pr 2.3.1) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1621 Rotigotine hydrochloride Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1622 Rotigotine nasal spray Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1623 Rotigotine transdermal patch Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1624 Rotigotine transdermal patch 2mg/24h(10cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1625 Rotigotine transdermal patch 4mg/24h (20cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1626 Rotigotine transdermal patch 6mg/24h (30cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1627 Rotigotine transdermal patch 8mg/24h (40cm2) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1628 Rotigotine tts (test) Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1629 Rotigotine, extended-release microspheres Rotigotine 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1630 Rozerem - - - - 1件:  6  💬
1631 Rq-00000010 - - - - 1件:  6  💬
1632 Rvg 08740 - - - - 1件:  6  💬
1633 Rvg 55618 - - - - 1件:  6  💬
1634 Rvt-101 35 mg - - - - 1件:  6  💬
1635 Rytary 145 mg - - - - 1件:  6  💬
1636 Rytary 195 mg - - - - 1件:  6  💬
1637 S 90049 - - - - 1件:  6  💬
1638 S 90049 - f36 - - - - 1件:  6  💬
1639 S 90049 - f38 - - - - 1件:  6  💬
1640 S.c. apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1641 S90049 - - - - 1件:  6  💬
1642 Sa - - - - 5件:  6 , 30, 60, 118, 298 💬
1643 Safety observation - - - - 1件:  6  💬
1644 Safinamida Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1645 Safinamide Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
1646 Safinamide (as add-on therapy) Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1647 Safinamide + levodopa Levodopa 2件: D00059, D10158 💬 6件: DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1648 Safinamide metansolfonato Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1649 Safinamide metansolfonato (12 weeks) Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1650 Safinamide methanesulfonate Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
1651 Safinamide methanesulfonate 100mg Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1652 Safinamide methanesulfonate 150mg Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1653 Safinamide methansulfonate Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1654 Safinamide, mao-b inhibitor Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1655 Safinimide 50-100 mg/day - - - - 1件:  6  💬
1656 Sage Sage - - - 1件:  6  💬
1657 Sage leaf Sage - - - 1件:  6  💬
1658 Sage-217 - - - - 1件:  6  💬
1659 Sage-718 - - - - 2件:  6 ,  8  💬
1660 Saline - - - - 10件:  6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
1661 Saline intranasal delivery - - - - 1件:  6  💬
1662 Sam - - - - 1件:  6  💬
1663 Sam-e Ademetionine 1件: D07128 💬 - - 1件:  6  💬
1664 Sar402671, gz402671 or gz/sar402671 - - - - 3件:  6 , 19, 67 💬
1665 Saracatinib Saracatinib 1件: D09664 💬 2件: ABL1, SRC 💬 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 3件:  6 , 89, 272 💬
1666 Sarcosine Sarcosine - - - 1件:  6  💬
1667 Sarcosine capsule Sarcosine - - - 1件:  6  💬
1668 Sargramostim Sargramostim 1件: D05803 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 7件:  6 , 28, 60, 62, 96, 229, 285 💬
1669 Sarizotan Sarizotan - - - 2件:  6 , 156 💬
1670 Sarizotan hc1 Sarizotan - - - 1件:  6  💬
1671 Sarizotan hcl Sarizotan - - - 1件:  6  💬
1672 Sarizotan hydrochloride Sarizotan - - - 2件:  6 , 156 💬
1673 Sch 420814 - - - - 1件:  6  💬
1674 Sch 420814 10 mg - - - - 1件:  6  💬
1675 Sch 420814 100 mg - - - - 1件:  6  💬
1676 Sch 900800 - - - - 1件:  6  💬
1677 Sch420814 - - - - 1件:  6  💬
1678 Selegiline Selegiline 2件: D00785, D03731 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1679 Selegiline hcl 5 pch Selegiline 2件: D00785, D03731 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1680 Semaglutide Semaglutide 1件: D10025 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
1681 Semi continuous intra-oral administration of ld/cd - - - - 1件:  6  💬
1682 Sep-363856 SEP-363856 - - - 1件:  6  💬
1683 Ser-214 - - - - 1件:  6  💬
1684 Serine Serine 1件: D00016 💬 - - 3件:  2 ,  6 , 86 💬
1685 Seroquel - - - - 1件:  6  💬
1686 Sertraline Sertraline 2件: D00825, D02360 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 206 💬
1687 Sevoflurane Sevoflurane 1件: D00547 💬 - - 6件:  6 , 21, 22, 34, 98, 296 💬
1688 Sifol - - - - 1件:  6  💬
1689 Sifrol - - - - 1件:  6  💬
1690 Sifrol 0,088 - - - - 1件:  6  💬
1691 Sifrol 0,18 - - - - 1件:  6  💬
1692 Sifrol 0,35 - - - - 1件:  6  💬
1693 Sifrol 0,7 - - - - 1件:  6  💬
1694 Sifrol, 0,35 mg tablette - - - - 1件:  6  💬
1695 Sifrol, 0,70 mg tablette - - - - 1件:  6  💬
1696 Sifrol, mirapexin - - - - 1件:  6  💬
1697 Sifrol® - - - - 1件:  6  💬
1698 Sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
1699 Silicon Silicon - - - 1件:  6  💬
1700 Silodosin Silodosin 1件: D01965 💬 1件: ADRA1A 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
1701 Simvastatin Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1702 Simvastatine Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 3件:  6 , 13, 288 💬
1703 Sinemet - - - - 1件:  6  💬
1704 Sinemet (carbidopa/levodopa) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1705 Sinemet (comparator) - - - - 1件:  6  💬
1706 Sinemet (levodopa/carbidopa) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1707 Sinemet 10-100 - - - - 1件:  6  💬
1708 Sinemet 100 mg + 25 mg compresse - - - - 1件:  6  💬
1709 Sinemet 125 - - - - 1件:  6  💬
1710 Sinemet 125 mg - - - - 1件:  6  💬
1711 Sinemet 200mg/50mg - - - - 1件:  6  💬
1712 Sinemet 25-100 - - - - 1件:  6  💬
1713 Sinemet 25/100 - - - - 1件:  6  💬
1714 Sinemet cr - - - - 1件:  6  💬
1715 Sinemet cr 25mg-100mg extended-release tablet - - - - 1件:  6  💬
1716 Sinemet ir - - - - 1件:  6  💬
1717 Sinemet plus - - - - 1件:  6  💬
1718 Sinemet plus (levodopa/carbidopa) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1719 Sinemet*50cpr 100mg+25mg - - - - 1件:  6  💬
1720 Sinemet-plus tablets - - - - 1件:  6  💬
1721 Sinemet® - - - - 1件:  6  💬
1722 Sinemet® 100/25 - - - - 1件:  6  💬
1723 Sinemet® 100/25 mg - - - - 1件:  6  💬
1724 Sinemet® controlled release (carbidopa/levodopa) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1725 Sinemet® cr - - - - 1件:  6  💬
1726 Sinemet® cr 100/25 - - - - 1件:  6  💬
1727 Sinemet® plus 25 mg/100 mg tablets - - - - 1件:  6  💬
1728 Sinemet®-plus tablets - - - - 1件:  6  💬
1729 Sinemet®25-100 - - - - 1件:  6  💬
1730 Sirio*30cpr eff 25mg+100mg - - - - 1件:  6  💬
1731 Sirolimus Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 35件:  6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬
1732 Sitagliptin Sitagliptin 1件: D08516 💬 1件: DPP4 💬 1件: Protein digestion and absorption 4件:  6 , 75, 233, 299 💬
1733 Sk&f101468 - - - - 1件:  6  💬
1734 Skf-101468a - - - - 1件:  6  💬
1735 Slv308 - - - - 1件:  6  💬
1736 Slv308 (mono) hydro - - - - 1件:  6  💬
1737 Slv308 (mono) hydrochlo - - - - 1件:  6  💬
1738 Slv308 (mono) hydrochlori - - - - 1件:  6  💬
1739 Slv308 (mono) hydrochloride - - - - 1件:  6  💬
1740 Slv308 (mono)hydrochloride - - - - 1件:  6  💬
1741 Slv308 hydrochloride - - - - 1件:  6  💬
1742 Slv308(mono)hydrochloride - - - - 1件:  6  💬
1743 Smilagenin Smilagenin - - - 1件:  6  💬
1744 Snd 919 cl2 y - - - - 1件:  6  💬
1745 Snd 919 cl2y - - - - 1件:  6  💬
1746 Snn0031 - - - - 1件:  6  💬
1747 Sodium chloride Chloride ion 1件: D02056 💬 - - 20件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬
1748 Sodium oxybate Sodium oxybate 1件: D05866 💬 - - 2件:  6 , 149 💬
1749 Solifenacin Solifenacin 2件: D01269, D08522 💬 1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 2件:  6 , 13 💬
1750 Solifenacin succinate (vesicare) Solifenacin 2件: D01269, D08522 💬 1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 1件:  6  💬
1751 Soligen - - - - 1件:  6  💬
1752 Solu-cortef - - - - 3件:  6 , 81, 83 💬
1753 Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' - - - - 1件:  6  💬
1754 Sorbitol Sorbitol 1件: D00096 💬 - - 2件:  6 , 10 💬
1755 Soy protein - - - - 2件:  6 , 96 💬
1756 Spect - - - - 1件:  6  💬
1757 Spheramine (bay86-5280) - - - - 1件:  6  💬
1758 Spiropent - - - - 2件:  6 , 13 💬
1759 Spm 926 - - - - 1件:  6  💬
1760 Spm 962 - - - - 1件:  6  💬
1761 Spm962 - - - - 1件:  6  💬
1762 Sqjz herbal mixtures - - - - 1件:  6  💬
1763 Sr57667b - - - - 1件:  6  💬
1764 Stalevo - - - - 1件:  6  💬
1765 Stalevo (levodopa/ carbidopa/ entacapone) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1766 Stalevo (levodopa/carbidopa/entacapona) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1767 Stalevo (levodopa/carbidopa/entacapone) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1768 Stalevo 100 - - - - 1件:  6  💬
1769 Stalevo 100 mg/ 25 mg/ 200 mg filmtabletten - - - - 1件:  6  💬
1770 Stalevo 100 mg/25 mg / 200 mg - - - - 1件:  6  💬
1771 Stalevo 100/25/200 mg - - - - 1件:  6  💬
1772 Stalevo 150 - - - - 1件:  6  💬
1773 Stalevo 150/37.5/200 mg - - - - 1件:  6  💬
1774 Stalevo*100cpr 100/25/200mg - - - - 1件:  6  💬
1775 Stalevo*100cpr 50/12,5/200mg - - - - 1件:  6  💬
1776 Stalevo® - - - - 1件:  6  💬
1777 Standard ld/cd - - - - 1件:  6  💬
1778 Standard of care - - - - 12件:  6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬
1779 Stilnoct - - - - 1件:  6  💬
1780 Strattera - - - - 1件:  6  💬
1781 Study drug - - - - 2件:  6 , 13 💬
1782 Subcutaneous apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1783 Subcutaneous hydrocortisone 10mg Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
1784 Subjects will undergo the 123-i ibvm imaging visit - - - - 1件:  6  💬
1785 Sugar pill - - - - 8件:  5 ,  6 , 49, 67, 70, 86, 206, 210 💬
1786 Sulfate Sulfate ion - - - 25件:  2 ,  6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
1787 Sumanirole Sumanirole - - - 1件:  6  💬
1788 Supplementation - - - - 1件:  6  💬
1789 Supressi. t-diet plus range - - - - 1件:  6  💬
1790 Suvorexant Suvorexant 1件: D10082 💬 2件: HCRTR1, HCRTR2 💬 1件: Neuroactive ligand-receptor interaction 3件:  5 ,  6 , 13 💬
1791 Syn115 - - - - 1件:  6  💬
1792 Syn115 tablets, 60 mg - - - - 1件:  6  💬
1793 Syn120 - - - - 1件:  6  💬
1794 Synthetic oxytocin Oxytocin 1件: D00089 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 1件:  6  💬
1795 Syntocinon - - - - 3件:  6 , 127, 193 💬
1796 Syntocinon 40 iu/ml nasal spray - - - - 1件:  6  💬
1797 Tacrolimus Tacrolimus 2件: D00107, D08556 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 32件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
1798 Tacrolimus tablets Tacrolimus 2件: D00107, D08556 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1799 Tadalafil Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 7件:  6 , 51, 75, 84, 86, 113, 210 💬
1800 Tak-071 - - - - 1件:  6  💬
1801 Talampanel Talampanel 1件: D02696 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 2件:  2 ,  6  💬
1802 Targinact 10 mg/5 mg prolonged-release tablets - - - - 2件:  6 , 226 💬
1803 Targinact 20 mg/10 mg prolonged-release tablets - - - - 1件:  6  💬
1804 Targinact 5 mg/2.5 mg prolonged-release tablets - - - - 1件:  6  💬
1805 Tasmar - - - - 2件:  6 , 28 💬
1806 Tavapadon Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1807 Tavapadon 0.25mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1808 Tavapadon 1mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1809 Tavapadon 5mg Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
1810 Tce - - - - 1件:  6  💬
1811 Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) Hydrogen - - - 1件:  6  💬
1812 Td-9855 - - - - 2件:  6 , 17 💬
1813 Technetium (99mtc) exametazime Exametazime 1件: D01109 💬 - - 1件:  6  💬
1814 Terazosin Terazosin 2件: D00610, D08569 💬 3件: ADRA1A, ADRA1B, ADRA1D 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
1815 Terazosin 5 mg Terazosin 2件: D00610, D08569 💬 3件: ADRA1A, ADRA1B, ADRA1D 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
1816 Tesofensine Tesofensine - - - 2件:  6 , 193 💬
1817 Thn02 - - - - 1件:  6  💬
1818 Thn102 dosage a - - - - 1件:  6  💬
1819 Thn102 dosage b - - - - 1件:  6  💬
1820 Thn102 dosage c - - - - 1件:  6  💬
1821 Tigan - - - - 1件:  6  💬
1822 Tigan® - - - - 1件:  6  💬
1823 To - - - - 1件:  6  💬
1824 Tocovid suprabio - - - - 1件:  6  💬
1825 Tolcapon Tolcapone 1件: D00786 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1826 Tolcapone Tolcapone 1件: D00786 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 3件:  6 , 28, 127 💬
1827 Tolubuterol hydrochloride - - - - 1件:  6  💬
1828 Topiramate Topiramate 1件: D00537 💬 36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 140, 144, 156, 193 💬
1829 Topiramate (drug) Topiramate 1件: D00537 💬 36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1830 Toz - - - - 1件:  6  💬
1831 Tozadenant Tozadenant 1件: D10174 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1832 Tozadenant (syn115) 120 mg bid Tozadenant 1件: D10174 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1833 Tozadenant (syn115) 180 mg bid Tozadenant 1件: D10174 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1834 Tozadenant (syn115) 240 mg bid Tozadenant 1件: D10174 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1835 Tozadenant (syn115) 60 mg bid Tozadenant 1件: D10174 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
1836 Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) - - - - 1件:  6  💬
1837 Transdermal flumazenil (added 4/2020) Flumazenil 1件: D00697 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1838 Transdermal nicotine Nicotine 3件: D03365, D05156, D05157 💬 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 1件:  6  💬
1839 Trigel - - - - 1件:  6  💬
1840 Trihexyphenidyl Trihexyphenidyl 2件: D00787, D08638 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  5 ,  6  💬
1841 Trimethobenzamide Trimethobenzamide 2件: D02733, D08643 💬 - - 1件:  6  💬
1842 Trimethobenzamide hydrochloride Trimethobenzamide 2件: D02733, D08643 💬 - - 1件:  6  💬
1843 Trivastal - - - - 1件:  6  💬
1844 Tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 19 💬
1845 Tryptophan Tryptophan 1件: D00020 💬 - - 1件:  6  💬
1846 Tryptophan (trp) depletion Tryptophan 1件: D00020 💬 - - 1件:  6  💬
1847 Tulobuterol Tulobuterol 1件: D02151 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1848 Tulobuterol hydrochloride Tulobuterol 1件: D02151 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
1849 Tvp-1012 - - - - 1件:  6  💬
1850 Tvp-1012 (1 mg/day) with levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1851 Tvp-1012 0.5mg - - - - 1件:  6  💬
1852 Tvp-1012 1mg - - - - 1件:  6  💬
1853 Tyramine Tyramine - - - 1件:  6  💬
1854 Tyrosine Tyrosine 1件: D00022 💬 - - 3件:  6 , 86, 111 💬
1855 Ub-312 - - - - 1件:  6  💬
1856 Ubiquinol Ubiquinol - - - 3件:  6 ,  8 , 17 💬
1857 Ucb0599 - - - - 1件:  6  💬
1858 Ucb7853 - - - - 1件:  6  💬
1859 Urate Uric acid - - - 1件:  6  💬
1860 Ursodeoxycholic acid Ursodeoxycholic acid 1件: D00734 💬 1件: NR1H4 💬 1件: Bile secretion 8件:  6 , 67, 84, 93, 94, 95, 96, 97 💬
1861 Ursonorm - - - - 1件:  6  💬
1862 Usual dopaminergic per os treatment - - - - 1件:  6  💬
1863 V1512 - - - - 1件:  6  💬
1864 V1512 and entacapone Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1865 V81444 - - - - 1件:  6  💬
1866 Valerian Valerian - - - 1件:  6  💬
1867 Varenicline Varenicline 1件: D08669 💬 2件: CHRNA4, CHRNB2 💬 3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 2件:  6 , 18 💬
1868 Varenicline tartrate Varenicline 1件: D08669 💬 2件: CHRNA4, CHRNB2 💬 3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 1件:  6  💬
1869 Variation of behaviors of parkinson's disease - - - - 1件:  6  💬
1870 Vehicle - - - - 4件:  6 , 36, 160, 192 💬
1871 Venglustat Venglustat 1件: D11633 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 3件:  6 , 19, 67 💬
1872 Venglustat malate Venglustat 1件: D11633 💬 1件: UGCG 💬 2件: Metabolic pathways, Sphingolipid metabolism 1件:  6  💬
1873 Venlafaxine Venlafaxine 2件: D00821, D08670 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 3件:  6 , 13, 46 💬
1874 Vineuro - - - - 1件:  6  💬
1875 Vitamin b12 Cyanocobalamin 4件: D00166, D03615, D03616, D03617 💬 - - 4件:  6 , 201, 229, 299 💬
1876 Vitamin b12 supplementation Cyanocobalamin 4件: D00166, D03615, D03616, D03617 💬 - - 1件:  6  💬
1877 Vitamin b6 Pyridoxine 2件: D02179, D08454 💬 - - 1件:  6  💬
1878 Vitamin d3 Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 11件:  6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬
1879 Vitamin d3 - high dose Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件:  6  💬
1880 Vitamin e Vitamin E 1件: D02331 💬 - - 11件:  2 ,  6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬
1881 Viusid/alzer - - - - 1件:  6  💬
1882 Vortioxetine Vortioxetine 1件: D10184 💬 7件: HTR1A, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E, SLC6A4 💬 5件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 1件:  6  💬
1883 Vr040 - - - - 1件:  6  💬
1884 Vr040/aspirair® inhaler - - - - 1件:  6  💬
1885 Vy-aadc01 - - - - 1件:  6  💬
1886 Vy-aadc02 - - - - 1件:  6  💬
1887 Warfarin Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
1888 Water Water 1件: D00001 💬 - - 22件:  2 ,  5 ,  6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬
1889 Wd-1603 - - - - 1件:  6  💬
1890 Wd-1603 carbidopa and levodopa extended-release tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1891 Wd-1603 carbidopa/levodopa extended-release tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1892 Whey protein - - - - 2件:  6 , 96 💬
1893 White chocolate (0% cocoa) Cocoa - - - 1件:  6  💬
1894 Win-1001x - - - - 1件:  6  💬
1895 Wuling powder - - - - 1件:  6  💬
1896 Xadago - - - - 2件:  6 , 17 💬
1897 Xadago (safinamide) Safinamide 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1898 Xc130-a10h - - - - 1件:  6  💬
1899 Xeomin - - - - 7件:  5 ,  6 ,  7 , 13, 15, 17, 113 💬
1900 Xiaoyao pill - - - - 1件:  6  💬
1901 Xp21279 - - - - 1件:  6  💬
1902 Xp21279 and carbidopa (experimental) Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
1903 Yohimbine Yohimbine 1件: D08685 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
1904 Yohimbine hcl Yohimbine 1件: D08685 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
1905 Zelapar - - - - 1件:  6  💬
1906 Zoledronic acid Zoledronic acid 4件: D01968, D06378, D06379, D08689 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 9件:  6 , 13, 46, 93, 95, 96, 274, 299, 333 💬
1907 Zoledronic acid 5mg/bag 100ml inj Zoledronic acid 4件: D01968, D06378, D06379, D08689 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 1件:  6  💬
1908 Zolmitriptan Zolmitriptan 1件: D00415 💬 2件: HTR1B, HTR1D 💬 4件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
1909 Zolpidem Zolpidem 2件: D00706, D08690 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 3件:  5 ,  6 , 46 💬
1910 Zolpidem first dose Zolpidem 2件: D00706, D08690 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1911 Zolpidem second dose Zolpidem 2件: D00706, D08690 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1912 Zolpidem tartrate Zolpidem 2件: D00706, D08690 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
1913 Zonegran - - - - 1件:  6  💬
1914 Zonisamide Zonisamide 1件: D00538 💬 8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 1件:  6  💬
1915 Zonisamide capsules Zonisamide 1件: D00538 💬 8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 1件:  6  💬
1916 Zopiclone Zopiclone 1件: D01372 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬

先頭へ